Data dictionary : SarcomaBCB

PATIENT (23 items)

File number
Type : Free value	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : Yes
Description : The unique file number the patient has in his centre

Birth date
Type : Free value	Content : DATE	Mandatory : Yes	Multiple values : No	Unique : No
Description : The patient's birth date

Sex
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : The patient's gender
Possible values : Female, Male

Centre (ConticaBase)
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Centre ConticaBase
Possible values : MEDIPATH Toulouse, Cabinet de Reims, Centre Patho de Metz, Cabinet de Douai, Cabinet d’Amiens, IHP Nantes, Centre Patho Dijon, Cabinet de la Roquette, Cabinet Mathurin, Lyon CLB, Hôp. Gabriel Montpied, CHRU De Dijon, Hôp. Pontchaillou, Hôp. Charles Nicolle, Hôp Pasteur, CHU Amiens, Labo. de Limoges, Service d'anapath de Brest, Cy-Path, Cabinet de Rennes, Villejuif IGR, Milan INT, Padova UNIPD, KLEUVEN, CHRU Lille, Saint-Louis, Bergonié, Curie, Mannheim, Nice CAL, Dijon CGFL, Caen CFB, Marseille IPC, Nancy ICL, Lille COL, Lausanne, Montpellier ICM, Angers ICO, Nantes ICO , IUCT Toulouse, Strasbourg CHU, Bruxelles, CJP, Paris Henri Mondor, Warsaw Cancer Center, Timone, Cochin, Rennes CEM, Heidelberg, Bonn, Tübingen, Haut-Lévèque Bordeaux, LUMC, Ambroise Paré APHP, Nantes CHU, Tours Trousseau, CPS Strasbourg, CHRU Montpellier, Limoges Dupuytren, Rouen CHB, Lyon IHOP, St Etienne ICLN-CHU, Reims IJG, Reims CHU, Besançon CHU, La Réunion CHU, Tenon, Bicêtre, Pitié Salpétrière, GHSN - LYON, Hôp. Civil Strasbourg, CHRU Caen, CHRU Brest, CHU Nancy, Rangueil Toulouse, Purpan Toulouse, Centre Hospitalier - Lille, CHRU Angers, Hôp. Nord Marseille, MEDIPATH (Frejus), APHP Bichat, APHP Saint-Antoine, Bordeaux Pellegrin, Lyon Edouard Herriot, CHR ORLEANS, Nice CHU, Cabinet Bièvres, CHU POITIERS, OUEST PATHOLOGIE, DIAG (Nice), GRP 2 RIVES, HPL, Centre François Baclesse Luxembourg, CHU ESTAIN , MEDIPATH (Toulon)

Creation date patient
Type : Free value	Content : DATE	Mandatory : Yes	Multiple values : No	Unique : No
Description : The date when the patient has been created in the database

Significant previous history
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description : No: no significant previous historyNF1: presence of neurofibromatosis type 1 or Recklinghausen diseaseNF2: presence of neurofibromatosis type 2Radiation therapy: tumour developed in a previously radiated areaLymphoedema: tumour developed on a preexisting lymphoedemaGardner: presence of a Gardner syndromLi Fraumeni: presence of a Li Fraumeni diseasePrevious cancer: the patient has previously developed another cancer different from the current tumourOther: other significant previous history with a possible link with the current tumour
Possible values : No, Previous cancer, NF1, NF2, Gardner syndrome, Li Fraumeni syndrome, Retinoblastoma syndrome, Immunodepressed - HIV, Immunodepressed - other, Ollier disease, Maffucci syndrome, Paget disease, Multiple osteochondromas, McCune-Albright syndrome, Rothmund-Thomson syndrome, Werner syndrome, Cherubism, Other genetic disease, Other, Unknown, Familial GISTs, Stratiakis-Carney dyad, Carney Triad, Other malignancy in family

Date of last contact
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of the last follow up evaluation or date of death

Significant previous history detail
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

Patient information
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Consent information
Possible values : Uninformed, Addressed mail, No opposition, Opposition, Consent

Initials
Type : Free value	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Patient initials : 4 characters (2 of Lastname, 2 of Firstname)Attention to compound names

Centre (RRePS)
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Centre RRePS
Possible values : Cabinet de Rennes, KLEUVEN, MEDIPATH Toulouse, Mannheim, Cabinet de Reims, Centre Patho de Metz, Lausanne, Cabinet de Douai, Nantes ICO , Cabinet d’Amiens, Bruxelles, IHP Nantes, Warsaw Cancer Center, Centre Patho Dijon, Heidelberg, Cabinet de la Roquette, Bonn, Cabinet Mathurin, Tübingen, LUMC, Lyon IHOP, St Etienne ICLN-CHU, Reims IJG, Reims CHU, La Réunion CHU, Tenon, Bordeaux Pellegrin, Bicêtre, Lyon CLB, Villejuif IGR, Hôp. Gabriel Montpied, CHRU De Dijon, Hôp. Pontchaillou, Hôp. Charles Nicolle, Hôp Pasteur, CHU Amiens, Labo. de Limoges, Service d'anapath de Brest, Cy-Path, Milan INT, Padova UNIPD, Saint-Louis, Bergonié, Curie, Nice CAL, Dijon CGFL, Caen CFB, Marseille IPC, Nancy ICL, Lille COL, Montpellier ICM, Angers ICO, IUCT Toulouse, Strasbourg CHU, CJP, Paris Henri Mondor, Timone, Cochin, Rennes CEM, Limoges Dupuytren, Tours Trousseau, Rouen CHB, Nantes CHU, Besançon CHU, Pitié Salpétrière, Haut-Lévèque Bordeaux, GHSN - LYON, Ambroise Paré APHP, CPS Strasbourg, Hôp. Civil Strasbourg, CHRU Caen, CHRU Brest, CHRU Montpellier, CHU Nancy, Rangueil Toulouse, Purpan Toulouse, CHRU Lille, CHRU Angers, Hôp. Nord Marseille, MEDIPATH (Frejus), APHP Bichat, APHP Saint-Antoine, Lyon Edouard Herriot, CHR ORLEANS, Nice CHU, Cabinet Bièvres, CHU POITIERS, OUEST PATHOLOGIE, DIAG (Nice), GRP 2 RIVES, HPL, Centre François Baclesse Luxembourg, CHU ESTAIN , MEDIPATH (Toulon)

Vital status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Vital status at last contact
Possible values : Alive, Dead

Cause of death
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Cause of death
Possible values : - Dead of this cancer - Primary cancer - Metastatic disease - Dead of other cancer - Dead of treatment complication - Dead of other cause - Unknown

Lost of follow-up
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Lost of follow-up
Possible values : No, Yes

Other cancer
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Has the patient another cancer
Possible values : Yes, No, Unknown

Date of death
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

Diagnosis during pregnancy
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Diagnosis during pregnancy (CALG network enrollment)
Possible values : Yes, No

Quality control NetSarc
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Quality control NetSarc performed
Possible values : Yes, No

Date of control
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of quality control

Centre (NetSarc)
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Centre NetSarc
Possible values : KLEUVEN, MEDIPATH Toulouse, Saint-Louis, Mannheim, Cabinet de Reims, Centre Patho de Metz, Lausanne, Cabinet de Douai, Cabinet d’Amiens, Bruxelles, IHP Nantes, Paris Henri Mondor, Warsaw Cancer Center, Centre Patho Dijon, Heidelberg, Cabinet de la Roquette, Bonn, Cabinet Mathurin, Tübingen, LUMC, St Etienne ICLN-CHU, Haut-Lévèque Bordeaux, GHSN - LYON, Ambroise Paré APHP, CPS Strasbourg, Hôp. Civil Strasbourg, CHRU Montpellier, CHU Nancy, Rangueil Toulouse, Purpan Toulouse, CHRU Lille, CHRU Angers, Hôp. Nord Marseille, MEDIPATH (Frejus), APHP Bichat, APHP Saint-Antoine, Bordeaux Pellegrin, Lyon Edouard Herriot, Villejuif IGR, Hôp. Gabriel Montpied, CHRU De Dijon, Hôp. Pontchaillou, Hôp. Charles Nicolle, Hôp Pasteur, CHU Amiens, Labo. de Limoges, Service d'anapath de Brest, Cy-Path, Milan INT, Padova UNIPD, Cabinet de Rennes, Lyon CLB, Bergonié, Curie, Nice CAL, Dijon CGFL, Caen CFB, Marseille IPC, Nancy ICL, Lille COL, Montpellier ICM, Angers ICO, Nantes ICO , IUCT Toulouse, Strasbourg CHU, CJP, Timone, Cochin, Rennes CEM, Limoges Dupuytren, Tours Trousseau, Rouen CHB, Lyon IHOP, Nantes CHU, Reims IJG, Reims CHU, Besançon CHU, La Réunion CHU, Tenon, Pitié Salpétrière, CHRU Caen, CHRU Brest, Bicêtre, CHR ORLEANS, Nice CHU, Cabinet Bièvres, CHU POITIERS, OUEST PATHOLOGIE, DIAG (Nice), GRP 2 RIVES, HPL, Centre François Baclesse Luxembourg, CHU ESTAIN , MEDIPATH (Toulon)

Centre (ResOS)
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Centre ResOS
Possible values : Lyon CLB, Warsaw Cancer Center, Cy-Path, Lyon Edouard Herriot, Lyon IHOP, Mannheim, Marseille IPC, MEDIPATH (Frejus), Milan INT, LUMC, Limoges Dupuytren, Lille COL, Lausanne, Labo. de Limoges, MEDIPATH Toulouse, La Réunion CHU, KLEUVEN, IHP Nantes, Montpellier ICM, Nancy ICL, Saint-Louis, Service d'anapath de Brest, St Etienne ICLN-CHU, Tenon, IUCT Toulouse, Tübingen, Villejuif IGR, Rouen CHB, Rennes CEM, Nantes ICO , Nice CAL, Padova UNIPD, Paris Henri Mondor, Pitié Salpétrière, Purpan Toulouse, Reims CHU, Reims IJG, Hôp. Pontchaillou, Hôp Pasteur, Angers ICO, Centre Patho de Metz, Centre Patho Dijon, Caen CFB, Cabinet de la Roquette, Cabinet d’Amiens, Cabinet de Rennes, Cabinet de Reims, Cabinet Mathurin, Cabinet de Douai, Bruxelles, Bonn, Bicêtre, Besançon CHU, Bergonié, Ambroise Paré APHP, APHP Saint-Antoine, APHP Bichat, CHRU Angers, CHRU Brest, GHSN - LYON, Curie, Dijon CGFL, Haut-Lévèque Bordeaux, Heidelberg, Hôp. Civil Strasbourg, Hôp. Nord Marseille, Hôp. Charles Nicolle, Hôp. Gabriel Montpied, CPS Strasbourg, CHRU Montpellier, CJP, CHRU Caen, CHRU De Dijon, CHU Amiens, Strasbourg CHU, Timone, Cochin, Tours Trousseau, Nantes CHU, CHU Nancy, Rangueil Toulouse, CHRU Lille, CHR ORLEANS, Bordeaux Pellegrin, Nice CHU, Cabinet Bièvres, CHU POITIERS, OUEST PATHOLOGIE, DIAG (Nice), GRP 2 RIVES, HPL, Centre François Baclesse Luxembourg, CHU ESTAIN , MEDIPATH (Toulon)

Quality control Conticabase
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

Date of control
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

PRIMARY_TUMOUR (142 items)

Site of tumour
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Site of tumour according to the scroll menu
Possible values : - Soft tissue - Head and neck - Superficial areas of head - Sinus and nasal fossa - Deep facial areas - Orbit - Anterior skull base - Ear - lateral skull base and nasoharynx - Oral cavity - oropharynx - Larynx - trachea - Visceral space of the neck - Neck NOS - Other - Trunk wall - Chest wall - Axilla - Abdominal wall - Trunk - paraspinal - Buttock - Groin - Internal trunk - Retroperitoneum - Peritoneum - Pelvis - Thorax internal - Large vessels - Paratesticular - Lower limb - Thigh - Knee - Leg - Ankle - Foot - Toe - Upper limb - Shoulder girdle - Upper arm - Elbow - Forearm - Wrist - Hand - Finger - Viscera - Gastro Intestinal tractus - Oesophagus - Stomach - Duodenum - Appendix - Small intestine - Colon - Rectum - Anus - Gyneacological area - Uterus - Ovary - Fallopian tube - Vagina - Vulva - Others - Breast - Lung - Heart - Pleura - Thymus - Thyroid - Kidney - Bladder - Ureter - Prostate - Testis - Epididymis - Penis - Spleen - Liver - Pancreas - Gallbladder - Salivary gland - Tonsil - Adrenal - Brain - Meninges - Lymph node - Bone - Skull and face bone - Skull NOS - Ethmoid - Superior maxilla - Mandible - Bone face - Upper airways - Larynx - Bronchus - Nasal septum - Spine - Cervical spine - Dorsal spine - Lumbar spine - Basin, sacrum, coccyx - Basin - Sacrum - Coccyx - Hip joint - Other thoracic bone - Rib - Sternum - Clavicle - Superior limb and shoulder - Bone shoulder girdle - Scapula - Shoulder joint - Humerus - Elbow joint - Ulna - Radius - Wirst joint - Hand bone NOS - Carpal (Hand) - Metacarpals (Hand) - Hand phalanges - Hand joint - Inferior limb - Femur - Patella - Knee joint - Tibia - Fibula - Ankle joint - Bone foot NOS - Tarsals (Foot) - Metatarsals (Foot) - Foot phalanges - Foot joint

Side (RESOS)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Laterality of bone tumour in human body
Possible values : Left, Right, Median, Unspecified, Not applicable

Size of tumour (mm)
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Largest diameter of the tumour expressed in mm

Depth of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Superficial: the tumour is located above the superficial aponeurosis with no involvement of this aponeurosis Deep: the tumour is located beneath the superficial aponeurosis with no involvement of the area above this aponeurosis. Involvement of the aponeurosis is possibleSuperficial and deep: the tumour is located above and beneath the superficial aponeurosis
Possible values : Superficial, Superficial and deep, Deep, Surface, Cortical, Intra-medullary

Loco-regional extension
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description : Tumour invasion of healthy adjacent tissues (NB: a deep intramuscular tumour systematically invades the adjacent muscle)
Possible values : No, Dermis, Hypodermis, Vasculo-nervous, Bone, Muscle, Adjacent organ

Multifocal tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : No: when tumour is only one entity Yes: when tumour is one entity associated with one or more nodules
Possible values : No, Yes

N
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes when there is a locoregional lymph node involvement detected by clinical and/or imaging evaluation
Possible values : No, Yes

M
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes when there is a distant metastasis diagnosed by imaging and / or histological evaluation
Possible values : Yes, No, Skip

Date of original diagnosis
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of the first sampling which allowed the diagnosis of the current tumour

Age at diagnosis
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description :

Surgery of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes, Curettage

Type of surgery of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Excision: removal of the tumour with no normal tissue at least of the surface of the tumour Wide resection: removal of the tumour with normal tissue covering all the surface of the tumour Compartimentectomy: removal of the tumour with all the tissues contained in an anatomical compartiment Amputation (of a limb or of the distal part of a limb such as a hand, foot or finger, 0)
Possible values : Excision, Wide resection, Compartimentectomy, Amputation

Margin R
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : R0: complete tumour resection at the macroscopic (surgeon, 0) and histological (pathologist, 0) levels R1: complete tumour resection at the macroscopic level (surgeon, 0) with tumour cells on the margins at the histological examination If the tumour is seen by the surgeon, it should be classified as R1. For most retroperitoneal tumours, the resection is R1. R2: incomplete tumour resection at the macroscopic level (surgeon, 0)
Possible values : R0, R1, R2, Not evaluable

Tumour spillage (CTCB)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Expert pathologist observed if the tumour was spilt
Possible values : Yes, No

Radiotherapy of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : No: no radiotherapy for the primary tumour First: radiotherapy has been the first treatment performed Second: radiotherapy has been performed after another treatment such as surgery
Possible values : No, First, Second, Third, Palliative

Dose of radiotherapy
Type : Free value	Content : DECIMAL	Mandatory : No	Multiple values : No	Unique : No
Description : Total dose of radiotherapy given to the entity and expressed in Grays

Complete remission after treatment
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : There is no evidence of residual tumour at the end of treatment of the tumour by clinical (and imaging when performed, 0) evaluation.
Possible values : Yes, No

Histotype
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Histotype of the primary tumour to be chosen in the scroll menu (2013 WHO classification, 0)
Possible values : - Benign lesion - Benign adipocytic tumours - Angiolipoma - Angiomyolipoma - Chondroid lipoma - Hibernoma - Lipoblastoma/lipoblastomatosis - Lipoma - Lipomatosis - Lipomatosis of nerve - Atypical spindle cell/pleomorphic lipomatous tumour - Myelolipoma - Myolipoma - Spindle cell / pleomorphic lipoma - Benign chondrogenic tumours - Chondroblastoma NOS - Chondroma - Chondromyxoid fibroma - Enchondroma - Osteochondroma - Osteochondromyxoma - Periosteal chondroma - Pulmonary chondroma - Pulmonary hamartoma - Subungueal exostosis - Synovial chondromatosis - Benign fibroblastic/myofibroblastic tumours - Adenofibroma - Angiofibroma - Angiomyofibroblastoma - Calcifying aponeurotic fibroma - Calcifying fibrous tumour - Cellular angiofibroma - Desmoplastic fibroblastoma - Elastofibroma - Fasciitis - Fibroblastic tumour with SMAD3 fusion - Fibrochondromyxoid tumour with THBS1 fusion - Fibro-osseous pseudotumour of digits - Fibroma of tendon sheath - Fibromatosis colli - Fibrous hamartoma of infancy - Gardner fibroma - Inclusion body fibromatosis - Intra-nodal palisaded myofibroblastoma - Ischaemic fasciitis - Juvenile hyaline fibromatosis - Myofibroblastoma - Myositis ossificans - Nasopharyngeal angiofibroma - Nodular fasciitis - Nuchal-type fibroma - Organ-associated pseudosarcomatous myofibroblastic proliferations - Other fibromas - Proliferative fasciitis - Proliferative myositis - Benign fibro-histiocytic tumours - Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws) - Deep benign fibrous histiocytoma - Epithelioid fibrous histiocytoma - Erdheim-Chester disease - Fibrous histiocytoma - Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma) - Langerhans cell histiocytosis - Non Ossifying fibroma - Rosai-Dorfman disease - Tenosynovial giant cell tumour NOS - Tenosynovial giant cell tumour, diffuse type - Tenosynovial giant cell tumour, localized type - Benign nerve sheath tumours - Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP - Benign Triton tumour - Dermal nerve sheath myxoma - Ectopic meningioma - Granular cell tumour - Hybrid nerve sheath tumours - Nasal glial heterotopia - Neurofibroma - Neurothekeoma - Perineurioma - Plexiform neurofibroma - Schwannoma - Solitary circumscribed neuroma - Benign notochordal tumour - Benign osteogenic tumours - Osteoid osteoma - Osteoma - Benign pericytic tumours - Angioleiomyoma - Glomus tumour - Myofibroma / myofibromatosis - Myopericytoma - Benign skeletal muscle tumours - Rhabdomyoma - Rhabdomyoma - adult type - Rhabdomyoma - fetal type - Rhabdomyoma - genital type - Benign smooth muscle tumours - Atypical polypoid adenomyoma - Adenomyoma - Bizarre nuclei leiomyoma - Cellular leiomyoma - Diffuse leiomyomatosis - Dissecans leiomyoma - Epithelioid leiomyoma - Intraveinous leiomyomatosis - Leiomyoma - Leiomyomatosis peritonealis disseminata - Mitotically-active leiomyoma - Myxoid leiomyoma - Benign tumours of uncertain differentiation - Acral fibromyxoma - Brown tumour - Deep (aggressive) angiomyxoma - Ectopic hamartomatous thymoma - Fibrous dysplasia - Inflammatory fibroid polyp - Intramuscular myxoma - Myxoma NOS - Osteofibrous dysplasia - Pleomorphic hyalinizing angiectatic tumour - Pleuropulmonary blastoma - Simple bone cyst - Superficial angiomyxoma - Benign vascular tumours - Angiolymphoid hyperplasia - Angiomatosis - Atypical vascular lesion - Diffuse pulmonary lymphangiomatosis - Epithelioid hemangioma - Gorham disease - Hemangioma - Intra-muscular hemangioma - Lymphangioma NOS - Lymphangiomatosis - Pyogenic granuloma - Osseous pseudo-tumours - Bizarre parosteal osteochondromatous proliferation - Callus - Florid ossificans periostitis - Post-traumatic fibro-osseous lesion - Tophaceous pseudogout - Other benign lesion - GIST - gastrointestinal stromal tumour (GIST), low, very low risk - gastrointestinal stromal tumour (GIST), intermediate risk - gastrointestinal stromal tumour (GIST), high risk - Non-mesenchymal malignant tumour - Carcinoma - Germinal tumor - Lymphoma - Melanoma - Myeloma - Other non-mesenchymal malignant tumours - Plasmocytoma - Other diagnoses - Diagnosis unspecified - Undifferentiated malignant tumour - Sarcoma - Chondrosarcoma - Central chondrosarcoma - Chondrosarcoma, grade 1 - Chondrosarcoma, grade 2 - Chondrosarcoma, grade 3 - Chondrosarcoma NOS - Clear cell chondrosarcoma - Dedifferentiated chondrosarcoma - Mesenchymal chondrosarcoma - Periosteal chondrosarcoma - Peripheral chondrosarcoma - Leiomyosarcoma - Leiomyosarcoma - differentiated - Leiomyosarcoma - epithelioid - Leiomyosarcoma - myxoid - Leiomyosarcoma - poorly-differentiated - Liposarcoma - Liposarcoma - dedifferentiated - Liposarcoma - mixed type - Liposarcoma - myxoid - Liposarcoma - NOS - Liposarcoma - pleomorphic - Liposarcoma - round cell - Liposarcoma - well differentiated - Myxoid pleomorphic liposarcoma - Malignant fibrohistiocytic tumours of bone - Malignant giant cell tumour of bone - Malignant peripheral nerve sheath tumour - Ectomesenchymoma - Malignant perineurioma - Malignant Triton tumour - MPNST - epithelioid type - MPNST - usual type - Miscellaneous sarcomas - Alveolar soft part sarcoma - Angiosarcoma - BCOR sarcoma - CIC-DUX sarcoma - CIC-rearranged sarcoma - Clear cell sarcoma - Desmoplastic round cell tumour - Epithelioid hemangioendothelioma NOS - Epithelioid hemangioendothelioma with TFE3 fusion - Epithelioid hemangioendothelioma with WWTR1 fusion - Epithelioid sarcoma - Ewing sarcoma - Extraskeletal myxoid chondrosarcoma - Fibrosarcoma NOS - High risk solitary fibrous tumour - Intimal sarcoma - Low grade fibromyxoid sarcoma - Low grade sinonasal sarcoma - Malignant glomus tumour - Malignant granular cell tumour - Malignant mesenchymoma - Malignant mixed tumor - Malignant myoepithelial tumour - Malignant ossifying fibromyxoid tumour - Malignant PECOMA - Malignant rhabdoid tumour - Malignant tenosynovial giant cell tumour - Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion - Sclerosing epithelioid fibrosarcoma - SMARCA4-deficient undifferentiated thoracic tumour - Myxofibrosarcoma - Osteosarcoma - Conventional osteosarcoma - Dedifferentiated low-grade central osteosarcoma - Dedifferentiated parosteal osteosarcoma - Extraskeletal osteosarcoma - High-grade surface osteosarcoma - Low-grade central osteosarcoma - Osteoblastoma-like osteosarcoma - Osteosarcoma NOS - Parosteal osteosarcoma - Periosteal osteosarcoma - Small cell osteosarcoma - Secondary osteosarcoma - Telangiectasic osteosarcoma - Other sarcomas - Adamantinoma - Adenosarcoma - Chondroid chordoma - Chordoma NOS - Dedifferentiated adamantimoma - Dedifferentiated chordoma - Endometrial stromal sarcoma - Endometrial stromal sarcoma - high-grade - Endometrial stromal sarcoma - low-grade - Phyllodes sarcoma - Poorly differenciated chordoma - Undifferentiated uterine sarcoma - Rhabdomyosarcoma - Adult spindle cell rhabdomyosarcoma - Alveolar rhabdomyosarcoma - Embryonal rhabdomyosarcoma - botryoid type - Embryonal rhabdomyosarcoma - NOS - Embryonal rhabdomyosarcoma - spindle cell type - Embryonal rhabdomyosarcoma - usual type - Pleomorphic rhabdomyosarcoma - Rhabdomyosarcoma - NOS - Rhabdomyosarcoma with MYOD1 mutation - Rhabdomyosarcoma with TFCP2 fusion - Rhabdomyosarcoma with VGLL2/NCOA2 fusion - Sclerosing rhabdomyosarcoma - Spindle cell rhabdomyosarcoma - Suspicion of sarcoma - Synovial sarcoma - Synovial sarcoma - biphasic - Synovial sarcoma - monophasic - Synovial sarcoma - NOS - Synovial sarcoma - poorly differentiated - Undifferentiated sarcoma - Undifferentiated epithelioid sarcoma - Undifferentiated pleomorphic sarcoma - Undifferentiated round cell sarcoma - Undifferentiated sarcoma - NOS - Undifferentiated spindle cell sarcoma - Tumour of intermediate malignancy - Atypical lipomatous tumour - Intermediate chondrogenic tumours - Atypical cartilaginous tumour - Cartilaginous tumour of uncertain prognosis - Chondromatosis NOS - Intermediate fibroblastic/myofibroblastic tumours - Dermatofibrosarcoma protuberans - Desmoid-type fibromatosis - Desmoplastic fibroma of bone - Fibro-osseous tumour of bone NOS - Fibrosarcomatous dermatofibrosarcoma protuberans - Giant cell fibroblastoma - Infantile fibrosarcoma - Inflammatory myofibroblastic tumour - Intermediate risk solitary fibrous tumour - Lipofibromatosis - Low grade myofibroblastic sarcoma - Low risk solitary fibrous tumour - Myxoinflammatory fibroblastic sarcoma - NTRK-rearranged spindle cell neoplasm - Palmar/plantar fibromatosis - Superficial CD34-positive fibroblastic tumour - Intermediate fibrohistiocytic tumours - Giant cell tumour of bone - Giant cell tumour of soft tissues - Metastatic giant cell tumour of bone - Osseous tumour rich in giant cell NOS - Plexiform fibrohistiocytic tumour - Suspicion of giant cell tumour of bone - Intermediate osteogenic tumours - Osteoblastoma NOS - Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma) - Intermediate peripheral nerve sheath tumour - Malignant melanotic neural tumour - Intermediate tumours of uncertain differentiation - Aneurysmal bone cyst - Angiomatoid fibrous histiocytoma - Atypical fibroxanthoma - Cutaneous pleomorphic sarcoma - Hemosiderotic fibrolipomatous tumour - Lymphangioleiomyoma/lymphangioleiomyomatosis - Malignant phosphaturic mesenchymal tumour - Melanotic neuroectodermal tumour of infancy - Mesenchymal tumor with GLI1 alteration - Mixed tumour - Myoepithelioma - Ossifying fibromyxoid tumour - PECOMA - NOS - Phosphaturic mesenchymal tumour NOS - Intermediate vascular tumours - Composite hemangioendothelioma - Epithelioid vascular tumour of bone NOS - Kaposi sarcoma - Kaposiform hemangioendothelioma - Papillary intralymphatic angioendothelioma - Pseudomyogenic hemangioendothelioma - Retiform hemangioendothelioma - Other tumours of intermediate malignancy - Atypical smooth muscle tumour - EBV-associated smooth muscle tumour (STUMP) - Endometrial stromal nodule - Endometrial stromal tumor low-grade - Inflammatory rhabdomyoblastic tumour - Metastatic leiomyoma - Smooth muscle tumour of undetermined malignant potential (STUMP) - Uterine tumour resembling ovarian sex cord tumours (UTROSCT) - Other intermediate mesenchymal tumour of bone - Mesenchymoma NOS - Osteofibrous dysplasia-like adamantinoma

Grade of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Histologic grade of the primary tumour according to the French grading system: tumour differentiation score 1 to 3, 0) + mitotic index (score 1 to 3, 0) + tumour necrosis (score 0 to 2, 0) Grade=1 for total score of 2 or 3 Grade=2 for total score of 4 or 5 Grade=3 for total score of 6, 7 or 8
Possible values : 1, 2, 3, NA

Isolated limb perfusion
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Isolated limb perfusion
Possible values : No, Yes

Radiation area
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : tumour developed in a previously irradiated area
Possible values : No, Yes

Lymphoedema
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : tumour developed in a region with a preexisting lymphoedema
Possible values : No, Yes

Clinical trial
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour
Possible values : No, Yes

Locoregional control
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : no residual tumour at the primary site by clinical and imaging examinations
Possible values : Yes, No, Not available

Date of surgery
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of surgery

AINS
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: when the patient was treated by AINS
Possible values : No, Yes

Hormonotherapy
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: when the patient was treated by hormonotherapy
Possible values : No, Yes

Cancer status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Cancer status at last contact
Possible values : No evidence of this cancer, Evidence of this cancer, Unknown, Not Applicable

Date 1st local progression
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

Quality of 1st surgery
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Qualité de la première chirurgie de la tumeur primaire. R0 : résection macroscopiquement pour le chirugien et microscopiquement complète pour l'anapath. Résection monobloc. (Tumeur non vue lors de la chirurgie) R1 : résection macroscopiquement complète Si le chirurgien a vu la tumeur la résection sera au mieux R1. R2 : Résection incomplète, énucléation.
Possible values : R0 margin, R1 margin, R2 margin, Margin not evaluable, Unknown

Progression
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Prend en compte la première progression locale et la première progression métastatique. Si elles sont simultannées les 2 dates sont identiques sinon elles sont différentes.
Possible values : No, Local, Metastatic, Local and metastatic, Not specify

Date 1st metastatic progression
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

Quality of re-excision
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Qualité de la reprise chirurgicale de la tumeur primaire. R0 margin no tumour was found : pas de reliquat tumoral retrouvé par l'anapath dans la pièce opératoire. R0 margin and tumour was found : présence d'un reliquat tumoral et résection microscopiquement complète. R1 margin and tumour was found : reliquat présent et résection macroscopiquement complète. R2 margin and tumour was found : reliquat présent et résection incomplète. Margin not evaluable : l'anapath dit que les marges ne sont pas évaluables.
Possible values : R0 margin no tumour was found, R0 margin and tumour was found, R1 margin and tumour was found, R2 margin and tumour was found, Margin not evaluable, Unknown

Type of biopsy
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Type de biopsie à visée de diagnostic avant la chirurgie. Open biopsy : biopsie chirurgicale ou incisionnelle Biopsy NOS : Biopsie SAI Not available : Information non disponible
Possible values : No, Microbiopsy, Open biopsy, Biopsy NOS, Microbiopsy and open biopsy, Cytology only, Not available

Mutation (GIST)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Y a-t-il eu une recherche de mutation de faite ? Réponse possible : Non Oui et le résultat est positif Oui et le résultat est négatif Oui et le résultat n'est pas interprétable.
Possible values : No, Yes positive, Yes negative, Yes not interpretable

RCP planned surgery quality
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : La qualité de la chirurgie a-t-elle été prévue par une des RCP précédant la chirurgie.?
Possible values : Yes, No

Neo-adj ttt before surgery
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Traitement néo-adjuvant avant la chirurgie
Possible values : Yes, No

Time of surgery
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : First, Second, Third

Diagnosis changed
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Modification de diagnostic (diagnostic redressé) suite à la relecture anapath. Exemple : en 2010 diagnostic de lipome relecture des lames en 2013 diagnostic de liposarcome le diagnostic est redressé donc Diagnosis changed = Yes. Exemple : diagnostic liposarcome bien différencié qui devient après rechute un liposarcome indifférentié. Diagnosis changed = No.
Possible values : No, Yes

Initial diagnosis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Quel était le diagnostic avant que le redressement de diag ?
Possible values : - Benign lesion - Benign adipocytic tumours - Angiolipoma - Angiomyolipoma - Chondroid lipoma - Hibernoma - Lipoblastoma/lipoblastomatosis - Lipoma - Lipomatosis - Lipomatosis of nerve - Atypical spindle cell/pleomorphic lipomatous tumour - Myelolipoma - Myolipoma - Spindle cell / pleomorphic lipoma - Benign chondrogenic tumours - Chondroblastoma NOS - Chondroma - Chondromyxoid fibroma - Enchondroma - Osteochondroma - Osteochondromyxoma - Periosteal chondroma - Pulmonary chondroma - Pulmonary hamartoma - Subungueal exostosis - Synovial chondromatosis - Benign fibroblastic/myofibroblastic tumours - Adenofibroma - Angiofibroma - Angiomyofibroblastoma - Calcifying aponeurotic fibroma - Calcifying fibrous tumour - Cellular angiofibroma - Desmoplastic fibroblastoma - Elastofibroma - Fasciitis - Fibroblastic tumour with SMAD3 fusion - Fibrochondromyxoid tumour with THBS1 fusion - Fibro-osseous pseudotumour of digits - Fibroma of tendon sheath - Fibromatosis colli - Fibrous hamartoma of infancy - Gardner fibroma - Inclusion body fibromatosis - Intra-nodal palisaded myofibroblastoma - Ischaemic fasciitis - Juvenile hyaline fibromatosis - Myofibroblastoma - Myositis ossificans - Nasopharyngeal angiofibroma - Nodular fasciitis - Nuchal-type fibroma - Organ-associated pseudosarcomatous myofibroblastic proliferations - Other fibromas - Proliferative fasciitis - Proliferative myositis - Benign fibro-histiocytic tumours - Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws) - Deep benign fibrous histiocytoma - Epithelioid fibrous histiocytoma - Erdheim-Chester disease - Fibrous histiocytoma - Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma) - Langerhans cell histiocytosis - Non Ossifying fibroma - Rosai-Dorfman disease - Tenosynovial giant cell tumour NOS - Tenosynovial giant cell tumour, diffuse type - Tenosynovial giant cell tumour, localized type - Benign nerve sheath tumours - Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP - Benign Triton tumour - Dermal nerve sheath myxoma - Ectopic meningioma - Granular cell tumour - Hybrid nerve sheath tumours - Nasal glial heterotopia - Neurofibroma - Neurothekeoma - Perineurioma - Plexiform neurofibroma - Schwannoma - Solitary circumscribed neuroma - Benign notochordal tumour - Benign osteogenic tumours - Osteoid osteoma - Osteoma - Benign pericytic tumours - Angioleiomyoma - Glomus tumour - Myofibroma / myofibromatosis - Myopericytoma - Benign skeletal muscle tumours - Rhabdomyoma - Rhabdomyoma - adult type - Rhabdomyoma - fetal type - Rhabdomyoma - genital type - Benign smooth muscle tumours - Atypical polypoid adenomyoma - Adenomyoma - Bizarre nuclei leiomyoma - Cellular leiomyoma - Diffuse leiomyomatosis - Dissecans leiomyoma - Epithelioid leiomyoma - Intraveinous leiomyomatosis - Leiomyoma - Leiomyomatosis peritonealis disseminata - Mitotically-active leiomyoma - Myxoid leiomyoma - Benign tumours of uncertain differentiation - Acral fibromyxoma - Brown tumour - Deep (aggressive) angiomyxoma - Ectopic hamartomatous thymoma - Fibrous dysplasia - Inflammatory fibroid polyp - Intramuscular myxoma - Myxoma NOS - Osteofibrous dysplasia - Pleomorphic hyalinizing angiectatic tumour - Pleuropulmonary blastoma - Simple bone cyst - Superficial angiomyxoma - Benign vascular tumours - Angiolymphoid hyperplasia - Angiomatosis - Atypical vascular lesion - Diffuse pulmonary lymphangiomatosis - Epithelioid hemangioma - Gorham disease - Hemangioma - Intra-muscular hemangioma - Lymphangioma NOS - Lymphangiomatosis - Pyogenic granuloma - Osseous pseudo-tumours - Bizarre parosteal osteochondromatous proliferation - Callus - Florid ossificans periostitis - Post-traumatic fibro-osseous lesion - Tophaceous pseudogout - Other benign lesion - GIST - gastrointestinal stromal tumour (GIST), low, very low risk - gastrointestinal stromal tumour (GIST), intermediate risk - gastrointestinal stromal tumour (GIST), high risk - Non-mesenchymal malignant tumour - Carcinoma - Germinal tumor - Lymphoma - Melanoma - Myeloma - Other non-mesenchymal malignant tumours - Plasmocytoma - Other diagnoses - Diagnosis unspecified - Undifferentiated malignant tumour - Sarcoma - Chondrosarcoma - Central chondrosarcoma - Chondrosarcoma, grade 1 - Chondrosarcoma, grade 2 - Chondrosarcoma, grade 3 - Chondrosarcoma NOS - Clear cell chondrosarcoma - Dedifferentiated chondrosarcoma - Mesenchymal chondrosarcoma - Periosteal chondrosarcoma - Peripheral chondrosarcoma - Leiomyosarcoma - Leiomyosarcoma - differentiated - Leiomyosarcoma - epithelioid - Leiomyosarcoma - myxoid - Leiomyosarcoma - poorly-differentiated - Liposarcoma - Liposarcoma - dedifferentiated - Liposarcoma - mixed type - Liposarcoma - myxoid - Liposarcoma - NOS - Liposarcoma - pleomorphic - Liposarcoma - round cell - Liposarcoma - well differentiated - Myxoid pleomorphic liposarcoma - Malignant fibrohistiocytic tumours of bone - Malignant giant cell tumour of bone - Malignant peripheral nerve sheath tumour - Ectomesenchymoma - Malignant perineurioma - Malignant Triton tumour - MPNST - epithelioid type - MPNST - usual type - Miscellaneous sarcomas - Alveolar soft part sarcoma - Angiosarcoma - BCOR sarcoma - CIC-DUX sarcoma - CIC-rearranged sarcoma - Clear cell sarcoma - Desmoplastic round cell tumour - Epithelioid hemangioendothelioma NOS - Epithelioid hemangioendothelioma with TFE3 fusion - Epithelioid hemangioendothelioma with WWTR1 fusion - Epithelioid sarcoma - Ewing sarcoma - Extraskeletal myxoid chondrosarcoma - Fibrosarcoma NOS - High risk solitary fibrous tumour - Intimal sarcoma - Low grade fibromyxoid sarcoma - Low grade sinonasal sarcoma - Malignant glomus tumour - Malignant granular cell tumour - Malignant mesenchymoma - Malignant mixed tumor - Malignant myoepithelial tumour - Malignant ossifying fibromyxoid tumour - Malignant PECOMA - Malignant rhabdoid tumour - Malignant tenosynovial giant cell tumour - Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion - Sclerosing epithelioid fibrosarcoma - SMARCA4-deficient undifferentiated thoracic tumour - Myxofibrosarcoma - Osteosarcoma - Conventional osteosarcoma - Dedifferentiated low-grade central osteosarcoma - Dedifferentiated parosteal osteosarcoma - Extraskeletal osteosarcoma - High-grade surface osteosarcoma - Low-grade central osteosarcoma - Osteoblastoma-like osteosarcoma - Osteosarcoma NOS - Parosteal osteosarcoma - Periosteal osteosarcoma - Small cell osteosarcoma - Secondary osteosarcoma - Telangiectasic osteosarcoma - Other sarcomas - Adamantinoma - Adenosarcoma - Chondroid chordoma - Chordoma NOS - Dedifferentiated adamantimoma - Dedifferentiated chordoma - Endometrial stromal sarcoma - Endometrial stromal sarcoma - high-grade - Endometrial stromal sarcoma - low-grade - Phyllodes sarcoma - Poorly differenciated chordoma - Undifferentiated uterine sarcoma - Rhabdomyosarcoma - Adult spindle cell rhabdomyosarcoma - Alveolar rhabdomyosarcoma - Embryonal rhabdomyosarcoma - botryoid type - Embryonal rhabdomyosarcoma - NOS - Embryonal rhabdomyosarcoma - spindle cell type - Embryonal rhabdomyosarcoma - usual type - Pleomorphic rhabdomyosarcoma - Rhabdomyosarcoma - NOS - Rhabdomyosarcoma with MYOD1 mutation - Rhabdomyosarcoma with TFCP2 fusion - Rhabdomyosarcoma with VGLL2/NCOA2 fusion - Sclerosing rhabdomyosarcoma - Spindle cell rhabdomyosarcoma - Suspicion of sarcoma - Synovial sarcoma - Synovial sarcoma - biphasic - Synovial sarcoma - monophasic - Synovial sarcoma - NOS - Synovial sarcoma - poorly differentiated - Undifferentiated sarcoma - Undifferentiated epithelioid sarcoma - Undifferentiated pleomorphic sarcoma - Undifferentiated round cell sarcoma - Undifferentiated sarcoma - NOS - Undifferentiated spindle cell sarcoma - Tumour of intermediate malignancy - Atypical lipomatous tumour - Intermediate chondrogenic tumours - Atypical cartilaginous tumour - Cartilaginous tumour of uncertain prognosis - Chondromatosis NOS - Intermediate fibroblastic/myofibroblastic tumours - Dermatofibrosarcoma protuberans - Desmoid-type fibromatosis - Desmoplastic fibroma of bone - Fibro-osseous tumour of bone NOS - Fibrosarcomatous dermatofibrosarcoma protuberans - Giant cell fibroblastoma - Infantile fibrosarcoma - Inflammatory myofibroblastic tumour - Intermediate risk solitary fibrous tumour - Lipofibromatosis - Low grade myofibroblastic sarcoma - Low risk solitary fibrous tumour - Myxoinflammatory fibroblastic sarcoma - NTRK-rearranged spindle cell neoplasm - Palmar/plantar fibromatosis - Superficial CD34-positive fibroblastic tumour - Intermediate fibrohistiocytic tumours - Giant cell tumour of bone - Giant cell tumour of soft tissues - Metastatic giant cell tumour of bone - Osseous tumour rich in giant cell NOS - Plexiform fibrohistiocytic tumour - Suspicion of giant cell tumour of bone - Intermediate osteogenic tumours - Osteoblastoma NOS - Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma) - Intermediate peripheral nerve sheath tumour - Malignant melanotic neural tumour - Intermediate tumours of uncertain differentiation - Aneurysmal bone cyst - Angiomatoid fibrous histiocytoma - Atypical fibroxanthoma - Cutaneous pleomorphic sarcoma - Hemosiderotic fibrolipomatous tumour - Lymphangioleiomyoma/lymphangioleiomyomatosis - Malignant phosphaturic mesenchymal tumour - Melanotic neuroectodermal tumour of infancy - Mesenchymal tumor with GLI1 alteration - Mixed tumour - Myoepithelioma - Ossifying fibromyxoid tumour - PECOMA - NOS - Phosphaturic mesenchymal tumour NOS - Intermediate vascular tumours - Composite hemangioendothelioma - Epithelioid vascular tumour of bone NOS - Kaposi sarcoma - Kaposiform hemangioendothelioma - Papillary intralymphatic angioendothelioma - Pseudomyogenic hemangioendothelioma - Retiform hemangioendothelioma - Other tumours of intermediate malignancy - Atypical smooth muscle tumour - EBV-associated smooth muscle tumour (STUMP) - Endometrial stromal nodule - Endometrial stromal tumor low-grade - Inflammatory rhabdomyoblastic tumour - Metastatic leiomyoma - Smooth muscle tumour of uncertain malignant potential (STUMP) - Smooth muscle tumour of undetermined malignant potential (STUMP) - Uterine tumour resembling ovarian sex cord tumours (UTROSCT) - Other intermediate mesenchymal tumour of bone - Mesenchymoma NOS - Osteofibrous dysplasia-like adamantinoma

Age at first sampling
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description :

StatusAtReferral
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : First event, Relapse

TTTBeforeReferral
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

ImagingBeforeTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : No, Ultrasound, CT Scan, MRI, X-Ray (standard radiograph), Other, Not available

Miettinen/AFIP
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Risque de malignité des GIST selon Miettinen
Possible values : Very low risk, Low risk, Intermediate risk, High risk, NA

DILP
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DRTEStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DRTEEnd
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DSytTTTStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DSystTTTEnd
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DHormonoTStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DAINSStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

IndicSystTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Neo-adjuvant, Adjuvant, Neo-adjuvant and adjuvant, Palliative, Not available

PathoFracture
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

ResidualTCells
Type : Free value	Content : PERCENTAGE	Mandatory : No	Multiple values : No	Unique : No
Description :

BoneReconstruction
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Prosthesis, Autograft, Biomaterials

ComplicationSurgery
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Henderson 1, Henderson 2, Henderson 3, Henderson 4

Re-excision
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Reprise chirurgicale tumeur primaire Ne sont prises en compte que les reprises chirurgicales ayant lieu avant la progression ou la rechute.
Possible values : No, Yes, Curettage

Surgeon
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Chirurgien qui a opéré la tumeur primaire Les chirurgiens Sarcome sont listés dans Network. Si la RCP propose que l'opération soit faite par un chirurgien particulier qui ne fait pas parti du réseau mais dont le nom est donné lors de la RCP il doit être saisi dans Referral to a specialized surgery outside network. Si le chirurgien ne correspond pas aux situations précédentes alors saisir Outside network.

Re-excision surgeon
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Chirurgien qui a ré-opéré la tumeur primaire Les chirurgiens sarcome sont listés dans Network. Si la RCP propose que la reprise soit faite par un chirurgien particulier qui ne fait pas parti du réseau mais dont le nom est donné lors de la RCP il doit être saisi dans Referral to a specialized surgery outside network. Si le chirurgien ne correspond pas aux situations précédentes alors saisir Outside network.

SystemicTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

Type of tumour
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : point de départ du développement de la tumeur
Possible values : Soft tissue, Viscera, Bone

OtherTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : No, Radiofrequency, Cryotherapy, Embolisation, Other

Performance status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : 0 Fully active, able to carry out all pre-disease performance without restriction1 (Restricted) impairment in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work2 Ambulatory and capable of all selfcare but unable to carry out any work activities for more than 50% of waking hours3 Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours4 Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair
Possible values : 0, 1, 2, 3, 4, NA

Mitotic Index / 50HPF
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description :

Date of review
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date à laquelle la relecture anapath a permis de redresser le diagnostic.

Final Diagnosis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Final diagnosis (computed)
Possible values : - Benign lesion - Benign adipocytic tumours - Angiolipoma - Angiomyolipoma - Chondroid lipoma - Hibernoma - Lipoblastoma/lipoblastomatosis - Lipoma - Lipomatosis - Lipomatosis of nerve - Myelolipoma - Atypical spindle cell/pleomorphic lipomatous tumour - Myolipoma - Spindle cell / pleomorphic lipoma - Benign chondrogenic tumours - Chondroblastoma NOS - Chondroma - Chondromyxoid fibroma - Enchondroma - Osteochondroma - Osteochondromyxoma - Periosteal chondroma - Pulmonary chondroma - Pulmonary hamartoma - Subungueal exostosis - Synovial chondromatosis - Benign fibroblastic/myofibroblastic tumours - Adenofibroma - Angiofibroma - Angiomyofibroblastoma - Calcifying aponeurotic fibroma - Calcifying fibrous tumour - Cellular angiofibroma - Desmoplastic fibroblastoma - Elastofibroma - Fasciitis - Fibroblastic tumour with SMAD3 fusion - Fibrochondromyxoid tumour with THBS1 fusion - Fibro-osseous pseudotumour of digits - Fibroma of tendon sheath - Fibromatosis colli - Fibrous hamartoma of infancy - Gardner fibroma - Inclusion body fibromatosis - Intra-nodal palisaded myofibroblastoma - Ischaemic fasciitis - Juvenile hyaline fibromatosis - Myofibroblastoma - Myositis ossificans - Nasopharyngeal angiofibroma - Nodular fasciitis - Nuchal-type fibroma - Organ-associated pseudosarcomatous myofibroblastic proliferations - Other fibromas - Proliferative fasciitis - Proliferative myositis - Benign fibro-histiocytic tumours - Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws) - Deep benign fibrous histiocytoma - Epithelioid fibrous histiocytoma - Fibrous histiocytoma - Erdheim-Chester disease - Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma) - Langerhans cell histiocytosis - Non Ossifying fibroma - Rosai-Dorfman disease - Tenosynovial giant cell tumour NOS - Tenosynovial giant cell tumour, diffuse type - Tenosynovial giant cell tumour, localized type - Benign nerve sheath tumours - Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP - Benign Triton tumour - Dermal nerve sheath myxoma - Ectopic meningioma - Granular cell tumour - Hybrid nerve sheath tumours - Nasal glial heterotopia - Neurofibroma - Neurothekeoma - Perineurioma - Plexiform neurofibroma - Schwannoma - Solitary circumscribed neuroma - Benign notochordal tumour - Benign osteogenic tumours - Osteoid osteoma - Osteoma - Benign pericytic tumours - Angioleiomyoma - Glomus tumour - Myofibroma / myofibromatosis - Myopericytoma - Benign skeletal muscle tumours - Rhabdomyoma - Rhabdomyoma - adult type - Rhabdomyoma - fetal type - Rhabdomyoma - genital type - Benign smooth muscle tumours - Adenomyoma - Atypical polypoid adenomyoma - Bizarre nuclei leiomyoma - Cellular leiomyoma - Diffuse leiomyomatosis - Dissecans leiomyoma - Epithelioid leiomyoma - Intraveinous leiomyomatosis - Leiomyoma - Leiomyomatosis peritonealis disseminata - Mitotically-active leiomyoma - Myxoid leiomyoma - Benign tumours of uncertain differentiation - Acral fibromyxoma - Brown tumour - Deep (aggressive) angiomyxoma - Ectopic hamartomatous thymoma - Fibrous dysplasia - Inflammatory fibroid polyp - Intramuscular myxoma - Myxoma NOS - Osteofibrous dysplasia - Pleomorphic hyalinizing angiectatic tumour - Pleuropulmonary blastoma - Simple bone cyst - Superficial angiomyxoma - Benign vascular tumours - Angiolymphoid hyperplasia - Angiomatosis - Atypical vascular lesion - Diffuse pulmonary lymphangiomatosis - Epithelioid hemangioma - Gorham disease - Hemangioma - Intra-muscular hemangioma - Lymphangiomatosis - Lymphangioma NOS - Pyogenic granuloma - Osseous pseudo-tumours - Bizarre parosteal osteochondromatous proliferation - Callus - Florid ossificans periostitis - Post-traumatic fibro-osseous lesion - Tophaceous pseudogout - Other benign lesion - GIST - gastrointestinal stromal tumour (GIST), low, very low risk - gastrointestinal stromal tumour (GIST), intermediate risk - gastrointestinal stromal tumour (GIST), high risk - Non-mesenchymal malignant tumour - Carcinoma - Germinal tumor - Lymphoma - Melanoma - Myeloma - Other non-mesenchymal malignant tumours - Plasmocytoma - Other diagnoses - Diagnosis unspecified - Undifferentiated malignant tumour - Sarcoma - Chondrosarcoma - Central chondrosarcoma - Chondrosarcoma, grade 1 - Chondrosarcoma, grade 2 - Chondrosarcoma, grade 3 - Chondrosarcoma NOS - Clear cell chondrosarcoma - Dedifferentiated chondrosarcoma - Mesenchymal chondrosarcoma - Periosteal chondrosarcoma - Peripheral chondrosarcoma - Leiomyosarcoma - Leiomyosarcoma - differentiated - Leiomyosarcoma - epithelioid - Leiomyosarcoma - myxoid - Leiomyosarcoma - poorly-differentiated - Liposarcoma - Liposarcoma - dedifferentiated - Liposarcoma - mixed type - Liposarcoma - myxoid - Liposarcoma - NOS - Liposarcoma - pleomorphic - Liposarcoma - round cell - Liposarcoma - well differentiated - Myxoid pleomorphic liposarcoma - Malignant fibrohistiocytic tumours of bone - Malignant giant cell tumour of bone - Malignant peripheral nerve sheath tumour - Ectomesenchymoma - Malignant perineurioma - Malignant Triton tumour - MPNST - epithelioid type - MPNST - usual type - Miscellaneous sarcomas - Fibrosarcoma NOS - Alveolar soft part sarcoma - Angiosarcoma - BCOR sarcoma - CIC-DUX sarcoma - CIC-rearranged sarcoma - Clear cell sarcoma - Desmoplastic round cell tumour - Epithelioid hemangioendothelioma NOS - Epithelioid hemangioendothelioma with TFE3 fusion - Epithelioid hemangioendothelioma with WWTR1 fusion - Epithelioid sarcoma - Ewing sarcoma - Extraskeletal myxoid chondrosarcoma - High risk solitary fibrous tumour - Intimal sarcoma - Low grade fibromyxoid sarcoma - Low grade sinonasal sarcoma - Malignant glomus tumour - Malignant granular cell tumour - Malignant mesenchymoma - Malignant mixed tumor - Malignant myoepithelial tumour - Malignant ossifying fibromyxoid tumour - Malignant PECOMA - Malignant rhabdoid tumour - Malignant tenosynovial giant cell tumour - Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion - Sclerosing epithelioid fibrosarcoma - SMARCA4-deficient undifferentiated thoracic tumour - Myxofibrosarcoma - Osteosarcoma - Conventional osteosarcoma - Dedifferentiated low-grade central osteosarcoma - Dedifferentiated parosteal osteosarcoma - Extraskeletal osteosarcoma - High-grade surface osteosarcoma - Low-grade central osteosarcoma - Osteoblastoma-like osteosarcoma - Osteosarcoma NOS - Parosteal osteosarcoma - Periosteal osteosarcoma - Small cell osteosarcoma - Secondary osteosarcoma - Telangiectasic osteosarcoma - Other sarcomas - Adamantinoma - Adenosarcoma - Chondroid chordoma - Chordoma NOS - Dedifferentiated adamantimoma - Dedifferentiated chordoma - Endometrial stromal sarcoma - Endometrial stromal sarcoma - high-grade - Endometrial stromal sarcoma - low-grade - Phyllodes sarcoma - Poorly differenciated chordoma - Undifferentiated uterine sarcoma - Rhabdomyosarcoma - Adult spindle cell rhabdomyosarcoma - Alveolar rhabdomyosarcoma - Embryonal rhabdomyosarcoma - botryoid type - Embryonal rhabdomyosarcoma - NOS - Embryonal rhabdomyosarcoma - spindle cell type - Embryonal rhabdomyosarcoma - usual type - Pleomorphic rhabdomyosarcoma - Rhabdomyosarcoma - NOS - Rhabdomyosarcoma with MYOD1 mutation - Rhabdomyosarcoma with TFCP2 fusion - Rhabdomyosarcoma with VGLL2/NCOA2 fusion - Sclerosing rhabdomyosarcoma - Spindle cell rhabdomyosarcoma - Suspicion of sarcoma - Synovial sarcoma - Synovial sarcoma - biphasic - Synovial sarcoma - monophasic - Synovial sarcoma - NOS - Synovial sarcoma - poorly differentiated - Undifferentiated sarcoma - Undifferentiated epithelioid sarcoma - Undifferentiated pleomorphic sarcoma - Undifferentiated round cell sarcoma - Undifferentiated sarcoma - NOS - Undifferentiated spindle cell sarcoma - Tumour of intermediate malignancy - Atypical lipomatous tumour - Intermediate chondrogenic tumours - Atypical cartilaginous tumour - Cartilaginous tumour of uncertain prognosis - Chondromatosis NOS - Intermediate fibroblastic/myofibroblastic tumours - Dermatofibrosarcoma protuberans - Desmoid-type fibromatosis - Desmoplastic fibroma of bone - Fibro-osseous tumour of bone NOS - Fibrosarcomatous dermatofibrosarcoma protuberans - Giant cell fibroblastoma - Infantile fibrosarcoma - Inflammatory myofibroblastic tumour - Intermediate risk solitary fibrous tumour - Lipofibromatosis - Low grade myofibroblastic sarcoma - Low risk solitary fibrous tumour - Myxoinflammatory fibroblastic sarcoma - NTRK-rearranged spindle cell neoplasm - Palmar/plantar fibromatosis - Superficial CD34-positive fibroblastic tumour - Intermediate fibrohistiocytic tumours - Giant cell tumour of bone - Giant cell tumour of soft tissues - Metastatic giant cell tumour of bone - Osseous tumour rich in giant cell NOS - Plexiform fibrohistiocytic tumour - Suspicion of giant cell tumour of bone - Intermediate osteogenic tumours - Osteoblastoma NOS - Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma) - Intermediate peripheral nerve sheath tumour - Malignant melanotic neural tumour - Intermediate tumours of uncertain differentiation - Aneurysmal bone cyst - Angiomatoid fibrous histiocytoma - Atypical fibroxanthoma - Cutaneous pleomorphic sarcoma - Hemosiderotic fibrolipomatous tumour - Lymphangioleiomyoma/lymphangioleiomyomatosis - Malignant phosphaturic mesenchymal tumour - Melanotic neuroectodermal tumour of infancy - Mesenchymal tumor with GLI1 alteration - Mixed tumour - Myoepithelioma - Ossifying fibromyxoid tumour - PECOMA - NOS - Phosphaturic mesenchymal tumour NOS - Intermediate vascular tumours - Composite hemangioendothelioma - Epithelioid vascular tumour of bone NOS - Kaposi sarcoma - Kaposiform hemangioendothelioma - Papillary intralymphatic angioendothelioma - Pseudomyogenic hemangioendothelioma - Retiform hemangioendothelioma - Other tumours of intermediate malignancy - Atypical smooth muscle tumour - EBV-associated smooth muscle tumour (STUMP) - Endometrial stromal nodule - Endometrial stromal tumor low-grade - Metastatic leiomyoma - Smooth muscle tumour of uncertain malignant potential (STUMP) - Smooth muscle tumour of undetermined malignant potential (STUMP) - Uterine tumour resembling ovarian sex cord tumours (UTROSCT) - Inflammatory rhabdomyoblastic tumour - Other intermediate mesenchymal tumour of bone - Mesenchymoma NOS - Osteofibrous dysplasia-like adamantinoma

FactG-GP1
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je manque d’énergie
Possible values : 0, 1, 2, 3, 4

FactG-GP2
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai des nausées
Possible values : 0, 1, 2, 3, 4

FactG-GP3
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : À cause de mon état physique, j’ai du mal à répondre aux besoins de ma famille
Possible values : 0, 1, 2, 3, 4

FactG-GP4
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai des douleurs
Possible values : 0, 1, 2, 3, 4

FactG-GP5
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je suis incommodé(e) par les effets secondaires du traitement
Possible values : 0, 1, 2, 3, 4

FactG-GP6
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je me sens malade
Possible values : 0, 1, 2, 3, 4

FactG-GP7
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je suis obligé(e) de passer du temps allongé(e)
Possible values : 0, 1, 2, 3, 4

FactG-GS1
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je me sens proche de mes amis
Possible values : 0, 1, 2, 3, 4

FactG-GS2
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Ma famille me soutient moralement
Possible values : 0, 1, 2, 3, 4

FactG-GS3
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Mes amis me soutiennent
Possible values : 0, 1, 2, 3, 4

FactG-GS4
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Ma famille a accepté ma maladie
Possible values : 0, 1, 2, 3, 4

FactG-GS5
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je suis satisfait(e) de la communication avec ma famille au sujet de ma maladie
Possible values : 0, 1, 2, 3, 4

FactG-GS6
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je me sens proche de mon (ma) partenaire (ou de la personne qui est mon principal soutien)
Possible values : 0, 1, 2, 3, 4

FactG-GS7
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je suis satisfait(e) de ma vie sexuelle
Possible values : 0, 1, 2, 3, 4

FactG-GE1
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je me sens triste
Possible values : 0, 1, 2, 3, 4

FactG-GE2
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je suis satisfait(e) de la façon dont je fais face à ma maladie
Possible values : 0, 1, 2, 3, 4

FactG-GE3
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je perds espoir dans le combat contre ma maladie
Possible values : 0, 1, 2, 3, 4

FactG-GE4
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je me sens nerveux (nerveuse)
Possible values : 0, 1, 2, 3, 4

FactG-GE5
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je suis préoccupé(e) par l’idée de mourir
Possible values : 0, 1, 2, 3, 4

FactG-GE6
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je suis préoccupé(e) à l’idée que mon état de santé puisse s’aggraver
Possible values : 0, 1, 2, 3, 4

FactG-GF1
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je suis capable de travailler (y compris le travail à la maison)
Possible values : 0, 1, 2, 3, 4

FactG-GF2
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Mon travail (y compris le travail à la maison) me donne de la satisfaction
Possible values : 0, 1, 2, 3, 4

FactG-GF3
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je suis capable de profiter de la vie
Possible values : 0, 1, 2, 3, 4

FactG-GF4
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai accepté ma maladie
Possible values : 0, 1, 2, 3, 4

FactG-GF5
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je dors bien
Possible values : 0, 1, 2, 3, 4

FactG-GF6
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’apprécie mes loisirs habituels
Possible values : 0, 1, 2, 3, 4

FactG-GF7
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je suis satisfait(e) de ma qualité de vie actuelle
Possible values : 0, 1, 2, 3, 4

FactCog-A1
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai eu du mal à construire mes pensées
Possible values : 0, 1, 2, 3, 4

FactCog-A3
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Ma pensée a été lente
Possible values : 0, 1, 2, 3, 4

FactCog-C7
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai eu du mal à me concentrer
Possible values : 0, 1, 2, 3, 4

FactCog-M9
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai eu du mal à trouver mon chemin pour me rendre dans un endroit familier
Possible values : 0, 1, 2, 3, 4

FactCog-M10
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai eu du mal à me souvenir de l’endroit où j’avais mis des choses, comme mes clés ou mon portefeuille
Possible values : 0, 1, 2, 3, 4

FactCog-M12
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai eu du mal à me souvenir d’informations nouvelles, comme des numéros de téléphone ou des instructions simples
Possible values : 0, 1, 2, 3, 4

FactCog-V13
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai eu du mal à me rappeler du nom d’un objet alors que j’étais en train de parler à quelqu’un
Possible values : 0, 1, 2, 3, 4

FactCog-V15
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai eu du mal à trouver le(s) mot(s) juste(s) pour m’exprimer
Possible values : 0, 1, 2, 3, 4

FactCog-V16
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai utilisé un mauvais mot pour désigner un objet
Possible values : 0, 1, 2, 3, 4

FactCog-V17b
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai eu du mal à exprimer ce que je voulais dire dans mes conversations avec d’autres personnes
Possible values : 0, 1, 2, 3, 4

FactCog-F19
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je suis entré(e) dans une pièce et j’ai oublié ce que j’avais l’intention d’y prendre ou d’y faire
Possible values : 0, 1, 2, 3, 4

FactCog-F23
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai dû faire de gros efforts pour être attentif(-ve), sinon je faisais des erreurs
Possible values : 0, 1, 2, 3, 4

FactCog-F24
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai oublié le nom de personnes peu de temps après qu’on me les ait présentées
Possible values : 0, 1, 2, 3, 4

FactCog-F25
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Mes réactions dans des situations de la vie de tous les jours ont été lentes
Possible values : 0, 1, 2, 3, 4

FactCog-C31
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai dû faire plus d’efforts que d’habitude pour garder le fil de ce que je faisais
Possible values : 0, 1, 2, 3, 4

FactCog-C32
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Ma pensée a été plus lente que d’habitude
Possible values : 0, 1, 2, 3, 4

FactCog-C33a
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai dû faire plus d’efforts que d’habitude pour m’exprimer clairement
Possible values : 0, 1, 2, 3, 4

FactCog-C33c
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai dû avoir recours à des listes écrites plus souvent que d’habitude pour ne pas oublier des choses
Possible values : 0, 1, 2, 3, 4

FactCog-MT1
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai du mal à garder le fil de ce que je fais si on m’interrompt
Possible values : 0, 1, 2, 3, 4

FactCog-MT2
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai du mal à faire des allers-retours entre différentes activités qui demandent de la réflexion
Possible values : 0, 1, 2, 3, 4

FactCog-O1
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Des personnes m’ont dit que je semblais avoir du mal à me souvenir d’informations
Possible values : 0, 1, 2, 3, 4

FactCog-O2
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Des personnes m’ont dit que je semblais avoir du mal à parler clairement
Possible values : 0, 1, 2, 3, 4

FactCog-O3
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Des personnes m’ont dit que je semblais avoir du mal à penser clairement
Possible values : 0, 1, 2, 3, 4

FactCog-O4
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Des personnes m’ont dit que je semblais avoir l’esprit confus
Possible values : 0, 1, 2, 3, 4

FactCog-PC1
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai été capable de me concentrer
Possible values : 0, 1, 2, 3, 4

FactCog-PV1
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai été capable de trouver les mots que je voulais utiliser en parlant à quelqu’un
Possible values : 0, 1, 2, 3, 4

FactCog-PM1
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai été capable de me souvenir de choses, comme de l’endroit où j’avais laissé mes clés ou mon portefeuille
Possible values : 0, 1, 2, 3, 4

FactCog-PM2
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : J’ai été capable de me souvenir de faire des choses, comme prendre mes médicaments ou acheter ce dont j’avais besoin
Possible values : 0, 1, 2, 3, 4

FactCog-PF1
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je suis capable d’être attentif(-ive) et de garder le fil de ce que je suis en train de faire sans effort supplémentaire
Possible values : 0, 1, 2, 3, 4

FactCog-PCH1
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Mon esprit est aussi vif qu’il l’a toujours été
Possible values : 0, 1, 2, 3, 4

FactCog-PCH2
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Ma mémoire est aussi bonne qu’elle l’a toujours été
Possible values : 0, 1, 2, 3, 4

FactCog-PMT1
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je suis capable de faire des allers-retours entre deux activités qui demandent de la réflexion
Possible values : 0, 1, 2, 3, 4

FactCog-PMT2
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Je suis capable de garder le fil de ce que je suis en train de faire, même si on m’interrompt
Possible values : 0, 1, 2, 3, 4

FactCog-Q35
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Ces problèmes m’ont contrarié(e)
Possible values : 0, 1, 2, 3, 4

FactCog-Q37
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Ces problèmes ont perturbé ma capacité à travailler
Possible values : 0, 1, 2, 3, 4

FactCog-Q38
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Ces problèmes ont perturbé ma capacité à faire des choses que j’aime
Possible values : 0, 1, 2, 3, 4

FactCog-Q41
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Ces problèmes ont perturbé ma qualité de vie
Possible values : 0, 1, 2, 3, 4

MOCA-Q1
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Visuospatial / Exécutif
Possible values : 0, 1, 2, 3, 4, 5

MOCA-Q2
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Dénomination
Possible values : 0, 1, 2, 3

MOCA-Q3
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Attention 1
Possible values : 0, 1, 2

MOCA-Q4
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Attention 2
Possible values : 0, 1

MOCA-Q5
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Attention 3
Possible values : 0, 1, 2, 3

MOCA-Q6
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Langage 1
Possible values : 0, 1, 2

MOCA-Q7
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Langage 2
Possible values : 0, 1

MOCA-Q8
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Abstraction
Possible values : 0, 1, 2

MOCA-Q9
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Rappel
Possible values : 0, 1, 2, 3, 4, 5

MOCA-Q10
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Orientation
Possible values : 0, 1, 2, 3, 4, 5, 6

MOCA-Q11
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Ajouter 1 point si scolarité <= 12 ans
Possible values : 0, 1

LOCAL_RECURRENCE (38 items)

Rank of local recurrence
Type : Free value	Content : INTEGER	Mandatory : Yes	Multiple values : No	Unique : No
Description : Rank of local recurrence

Date of local recurrence
Type : Free value	Content : DATE	Mandatory : Yes	Multiple values : No	Unique : No
Description : Date of diagnosis of the first local recurrence

Size of tumour (mm)
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Largest diameter of the tumour expressed in mm

Depth of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Superficial: the tumour is located above the superficial aponeurosis with no involvement of this aponeurosis Deep: the tumour is located beneath the superficial aponeurosis with no involvement of the area above this aponeurosis. Involvement of the aponeurosis is possibleSuperficial and deep: the tumour is located above and beneath the superficial aponeurosis
Possible values : Superficial, Superficial and deep, Deep, Surface, Cortical, Intra-medullary

Multifocal tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : No: when tumour is only one entity Yes: when tumour is one entity associated with one or more nodules
Possible values : No, Yes

Surgery of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes, Curettage

Type of surgery of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Excision: removal of the tumour with no normal tissue at least of the surface of the tumour Wide resection: removal of the tumour with normal tissue covering all the surface of the tumour Compartimentectomy: removal of the tumour with all the tissues contained in an anatomical compartiment Amputation (of a limb or of the distal part of a limb such as a hand, foot or finger, 0)
Possible values : Excision, Wide resection, Compartimentectomy, Amputation

Margin R
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : R0: complete tumour resection at the macroscopic (surgeon, 0) and histological (pathologist, 0) levels R1: complete tumour resection at the macroscopic level (surgeon, 0) with tumour cells on the margins at the histological examination If the tumour is seen by the surgeon, it should be classified as R1. For most retroperitoneal tumours, the resection is R1. R2: incomplete tumour resection at the macroscopic level (surgeon, 0)
Possible values : R0, R1, R2, Not evaluable

Tumour spillage (CTCB)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Expert pathologist observed if the tumour was spilt
Possible values : Yes, No

Radiotherapy of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : No: no radiotherapy for the primary tumour First: radiotherapy has been the first treatment performed Second: radiotherapy has been performed after another treatment such as surgery
Possible values : No, First, Second, Third, Palliative

Complete remission after treatment
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : There is no evidence of residual tumour at the end of treatment of the tumour by clinical (and imaging when performed, 0) evaluation.
Possible values : Yes, No

Dose of radiotherapy
Type : Free value	Content : DECIMAL	Mandatory : No	Multiple values : No	Unique : No
Description : Total dose of radiotherapy given to the entity and expressed in Grays

Isolated limb perfusion
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Isolated limb perfusion
Possible values : No, Yes

Performance status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : 0 Fully active, able to carry out all pre-disease performance without restriction1 (Restricted) impairment in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work2 Ambulatory and capable of all selfcare but unable to carry out any work activities for more than 50% of waking hours3 Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours4 Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair
Possible values : 0, 1, 2, 3, 4, NA

Radiation area
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : tumour developed in a previously irradiated area
Possible values : No, Yes

Clinical trial
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour
Possible values : No, Yes

Locoregional control
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : no residual tumour at the primary site by clinical and imaging examinations
Possible values : Yes, No, Not available

Date of surgery
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of surgery

Time of surgery
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : First, Second, Third

PathoFracture
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

SurgeonLR
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Network, Outside Network

ReExcisionSurgeonLR
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Network, Outside Network

DILP
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DRTEStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DRTEEnd
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DSytTTTStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DSystTTTEnd
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DHormonoTStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DAINSStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

IndicSystTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Neo-adjuvant, Adjuvant, Neo-adjuvant and adjuvant, Palliative, Not available

ResidualTCells
Type : Free value	Content : PERCENTAGE	Mandatory : No	Multiple values : No	Unique : No
Description :

BoneReconstruction
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Prosthesis, Autograft, Biomaterials

ComplicationSurgery
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Henderson 1, Henderson 2, Henderson 3, Henderson 4

Re-excision
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Reprise chirurgicale tumeur primaire Ne sont prises en compte que les reprises chirurgicales ayant lieu avant la progression ou la rechute.
Possible values : No, Yes, Curettage

AINS
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: when the patient was treated by AINS
Possible values : No, Yes

Hormonotherapy
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: when the patient was treated by hormonotherapy
Possible values : No, Yes

SystemicTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

OtherTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : No, Radiofrequency, Cryotherapy, Embolisation, Other

METASTASIS (8 items)

Date of first metastasis
Type : Free value	Content : DATE	Mandatory : Yes	Multiple values : No	Unique : No
Description : Date of diagnosis of the first metastasis

Location of first metastasis
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : Yes	Unique : No
Description : Location of first metastasis
Possible values : Bone, Bone marrow, Brain, Liver, Lung, Lymph node, Peritoneum, Pleura, Skin, Soft tissues, Other

Location of further metastasis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description : Location of further metastasis
Possible values : Bone, Bone marrow, Brain, Liver, Lung, Lymph node, Peritoneum, Pleura, Skin, Soft tissues, Other, No

Number of metastatic sites
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Number of metastasic sites at diagnosis

Locoregional treatment of metastasis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description : Choose one or several (CTRL + clic) type(s) of locoregional treatment for the treatment of metastasis
Possible values : Surgery, Radiofrequency, Cryotherapy, Radiotherapy, Other

TTTM
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : No, Systemic treatment, Locoregional treatment, AINS, Other

IndicSystTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Neo-adjuvant, Adjuvant, Neo-adjuvant and adjuvant, Palliative, Not available

Clinical trial
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour
Possible values : No, Yes

SAMPLE (58 items)

Sample reference
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : Yes
Description : The sample reference in the center

Type of sampling
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Microbiopsy: sampling of the tumour with a core needleOpen biopsy: surgical resection of a piece of the tumour with a diagnostic intendTumour resection: surgical resection of the whole tumour
Possible values : Microbiopsy, Open biopsy, Tumour resection, Curettage

Treatment before sampling
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description : No : no treatment of the tumour event before sampling Chemotherapy: the tumour event has been received a chemotherapy before sampling Radiotherapy: radiotherapy on the tumour event before sampling ILP: an isolated limb perfusion procedure has been performed on the tumour event before sampling Other: other treatment has been performed on the tumour event before sampling
Possible values : No, Systemic treatment, Radiotherapy, ILP, Other

Date of sampling
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date on which the sample was removed

Metastasis sample location
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Location of this metastasis sample (only for metastasis sample)
Possible values : Bone, Bone marrow, Brain, Liver, Lung, Lymph node, Peritoneum, Pleura, Skin, Soft tissues, Other

Mitotic count / 5mm² (ACP)
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Mitotic count / 5mm² observed by the initial pathologist worked in the ACP structure

AFIP classification (ACP)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : AFIP classification calculated by the initial pathologist
Possible values : Very low risk, Low risk, Intermediate risk, High risk

Mitotic count / 5mm² (RC)
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Mitotic count / 5mm² observed by the expert pathologist worked in the Regional Center

AFIP classification (RC)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : AFIP classification calculated in the Regional Center
Possible values : Very low risk, Low risk, Intermediate risk, High risk

Mitotic count / 5mm² (NC)
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Mitotic count / 5mm² observed by the expert pathologist worked in the National Center

AFIP classification (NC)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : AFIP classification calculated in the National Center
Possible values : Very low risk, Low risk, Intermediate risk, High risk

Meeting AFIP classification
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : AFIP classification calculated by several experts pathologists during the national reviewing
Possible values : Very low risk, Low risk, Intermediate risk, High risk

Mitotic count / 5mm² (Meeting)
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Mitotic count / 5mm² observed by the experts pathologists during the national reviewing

Case origin
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Origin of the sample
Possible values : Centre, Outside sampling, Systematic review, Second opinion

ACP Reference
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Sample reference in ACP structure

RC Reference
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Sample reference in the Regional Center

NC Reference
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Sample reference in the National Center

RC Reception date
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : When the sample was received in the Regional Center

NC Reception date
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : When the sample was received in the National Center

RC Diagnosis date
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of diagnosis made by the pathologist in the Regional Center

NC Diagnosis date
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of diagnosis made by the pathologist in the National Center

Meeting review
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Sample reviewed by several experts pathologists during the national reviewing
Possible values : No, Yes

ACP Reviewer
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Initial pathologist

ACP Diagnosis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Diagnosis made by the initial pathologist
Possible values : - Benign lesion - Benign adipocytic tumours - Angiolipoma - Angiomyolipoma - Chondroid lipoma - Hibernoma - Lipoblastoma/lipoblastomatosis - Lipoma - Lipomatosis - Lipomatosis of nerve - Atypical spindle cell/pleomorphic lipomatous tumour - Myelolipoma - Myolipoma - Spindle cell / pleomorphic lipoma - Benign chondrogenic tumours - Chondroma - Enchondroma - Osteochondroma - Chondroblastoma NOS - Chondromyxoid fibroma - Osteochondromyxoma - Periosteal chondroma - Pulmonary chondroma - Pulmonary hamartoma - Subungueal exostosis - Synovial chondromatosis - Benign fibroblastic/myofibroblastic tumours - Adenofibroma - Angiofibroma - Angiomyofibroblastoma - Calcifying aponeurotic fibroma - Calcifying fibrous tumour - Cellular angiofibroma - Desmoplastic fibroblastoma - Elastofibroma - Fasciitis - Fibroblastic tumour with SMAD3 fusion - Fibrochondromyxoid tumour with THBS1 fusion - Fibro-osseous pseudotumour of digits - Fibroma of tendon sheath - Fibromatosis colli - Fibrous hamartoma of infancy - Gardner fibroma - Inclusion body fibromatosis - Intra-nodal palisaded myofibroblastoma - Ischaemic fasciitis - Juvenile hyaline fibromatosis - Myofibroblastoma - Myositis ossificans - Nasopharyngeal angiofibroma - Nodular fasciitis - Nuchal-type fibroma - Organ-associated pseudosarcomatous myofibroblastic proliferations - Other fibromas - Proliferative fasciitis - Proliferative myositis - Benign fibro-histiocytic tumours - Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws) - Deep benign fibrous histiocytoma - Epithelioid fibrous histiocytoma - Erdheim-Chester disease - Fibrous histiocytoma - Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma) - Langerhans cell histiocytosis - Non Ossifying fibroma - Rosai-Dorfman disease - Tenosynovial giant cell tumour NOS - Tenosynovial giant cell tumour, diffuse type - Tenosynovial giant cell tumour, localized type - Benign nerve sheath tumours - Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP - Benign Triton tumour - Dermal nerve sheath myxoma - Ectopic meningioma - Granular cell tumour - Hybrid nerve sheath tumours - Nasal glial heterotopia - Neurofibroma - Neurothekeoma - Perineurioma - Plexiform neurofibroma - Schwannoma - Solitary circumscribed neuroma - Benign notochordal tumour - Benign osteogenic tumours - Osteoid osteoma - Osteoma - Benign pericytic tumours - Angioleiomyoma - Glomus tumour - Myofibroma / myofibromatosis - Myopericytoma - Benign skeletal muscle tumours - Rhabdomyoma - Rhabdomyoma - adult type - Rhabdomyoma - fetal type - Rhabdomyoma - genital type - Benign smooth muscle tumours - Adenomyoma - Atypical polypoid adenomyoma - Bizarre nuclei leiomyoma - Cellular leiomyoma - Diffuse leiomyomatosis - Dissecans leiomyoma - Epithelioid leiomyoma - Intraveinous leiomyomatosis - Leiomyoma - Leiomyomatosis peritonealis disseminata - Mitotically-active leiomyoma - Myxoid leiomyoma - Benign tumours of uncertain differentiation - Acral fibromyxoma - Brown tumour - Deep (aggressive) angiomyxoma - Ectopic hamartomatous thymoma - Fibrous dysplasia - Inflammatory fibroid polyp - Intramuscular myxoma - Myxoma NOS - Osteofibrous dysplasia - Pleomorphic hyalinizing angiectatic tumour - Pleuropulmonary blastoma - Simple bone cyst - Superficial angiomyxoma - Benign vascular tumours - Angiolymphoid hyperplasia - Angiomatosis - Atypical vascular lesion - Diffuse pulmonary lymphangiomatosis - Epithelioid hemangioma - Gorham disease - Hemangioma - Intra-muscular hemangioma - Lymphangioma NOS - Lymphangiomatosis - Pyogenic granuloma - Osseous pseudo-tumours - Bizarre parosteal osteochondromatous proliferation - Callus - Florid ossificans periostitis - Post-traumatic fibro-osseous lesion - Tophaceous pseudogout - Other benign lesion - GIST - gastrointestinal stromal tumour (GIST), low, very low risk - gastrointestinal stromal tumour (GIST), intermediate risk - gastrointestinal stromal tumour (GIST), high risk - Non-mesenchymal malignant tumour - Carcinoma - Germinal tumor - Lymphoma - Melanoma - Myeloma - Other non-mesenchymal malignant tumours - Plasmocytoma - Other diagnoses - Diagnosis unspecified - Undifferentiated malignant tumour - Sarcoma - Chondrosarcoma - Central chondrosarcoma - Chondrosarcoma, grade 1 - Chondrosarcoma, grade 2 - Chondrosarcoma, grade 3 - Chondrosarcoma NOS - Clear cell chondrosarcoma - Dedifferentiated chondrosarcoma - Mesenchymal chondrosarcoma - Periosteal chondrosarcoma - Peripheral chondrosarcoma - Leiomyosarcoma - Leiomyosarcoma - differentiated - Leiomyosarcoma - epithelioid - Leiomyosarcoma - myxoid - Leiomyosarcoma - poorly-differentiated - Liposarcoma - Liposarcoma - dedifferentiated - Liposarcoma - mixed type - Liposarcoma - myxoid - Liposarcoma - NOS - Liposarcoma - pleomorphic - Liposarcoma - round cell - Liposarcoma - well differentiated - Myxoid pleomorphic liposarcoma - Malignant fibrohistiocytic tumours of bone - Malignant giant cell tumour of bone - Malignant peripheral nerve sheath tumour - Ectomesenchymoma - Malignant perineurioma - Malignant Triton tumour - MPNST - epithelioid type - MPNST - usual type - Miscellaneous sarcomas - Alveolar soft part sarcoma - Angiosarcoma - BCOR sarcoma - CIC-DUX sarcoma - CIC-rearranged sarcoma - Clear cell sarcoma - Desmoplastic round cell tumour - Epithelioid hemangioendothelioma NOS - Epithelioid hemangioendothelioma with TFE3 fusion - Epithelioid hemangioendothelioma with WWTR1 fusion - Epithelioid sarcoma - Ewing sarcoma - Extraskeletal myxoid chondrosarcoma - Fibrosarcoma NOS - High risk solitary fibrous tumour - Intimal sarcoma - Low grade fibromyxoid sarcoma - Low grade sinonasal sarcoma - Malignant glomus tumour - Malignant granular cell tumour - Malignant mesenchymoma - Malignant mixed tumor - Malignant myoepithelial tumour - Malignant ossifying fibromyxoid tumour - Malignant PECOMA - Malignant rhabdoid tumour - Malignant tenosynovial giant cell tumour - Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion - Sclerosing epithelioid fibrosarcoma - SMARCA4-deficient undifferentiated thoracic tumour - Myxofibrosarcoma - Osteosarcoma - Conventional osteosarcoma - Dedifferentiated low-grade central osteosarcoma - Dedifferentiated parosteal osteosarcoma - Extraskeletal osteosarcoma - High-grade surface osteosarcoma - Low-grade central osteosarcoma - Osteoblastoma-like osteosarcoma - Osteosarcoma NOS - Parosteal osteosarcoma - Periosteal osteosarcoma - Small cell osteosarcoma - Secondary osteosarcoma - Telangiectasic osteosarcoma - Other sarcomas - Adamantinoma - Adenosarcoma - Chondroid chordoma - Chordoma NOS - Dedifferentiated adamantimoma - Dedifferentiated chordoma - Endometrial stromal sarcoma - Endometrial stromal sarcoma - high-grade - Endometrial stromal sarcoma - low-grade - Phyllodes sarcoma - Poorly differenciated chordoma - Undifferentiated uterine sarcoma - Rhabdomyosarcoma - Adult spindle cell rhabdomyosarcoma - Alveolar rhabdomyosarcoma - Embryonal rhabdomyosarcoma - botryoid type - Embryonal rhabdomyosarcoma - NOS - Embryonal rhabdomyosarcoma - spindle cell type - Embryonal rhabdomyosarcoma - usual type - Pleomorphic rhabdomyosarcoma - Rhabdomyosarcoma - NOS - Rhabdomyosarcoma with MYOD1 mutation - Rhabdomyosarcoma with TFCP2 fusion - Rhabdomyosarcoma with VGLL2/NCOA2 fusion - Sclerosing rhabdomyosarcoma - Spindle cell rhabdomyosarcoma - Suspicion of sarcoma - Synovial sarcoma - Synovial sarcoma - biphasic - Synovial sarcoma - monophasic - Synovial sarcoma - NOS - Synovial sarcoma - poorly differentiated - Undifferentiated sarcoma - Undifferentiated epithelioid sarcoma - Undifferentiated pleomorphic sarcoma - Undifferentiated round cell sarcoma - Undifferentiated sarcoma - NOS - Undifferentiated spindle cell sarcoma - Tumour of intermediate malignancy - Atypical lipomatous tumour - Intermediate chondrogenic tumours - Atypical cartilaginous tumour - Cartilaginous tumour of uncertain prognosis - Chondromatosis NOS - Intermediate fibroblastic/myofibroblastic tumours - Dermatofibrosarcoma protuberans - Desmoid-type fibromatosis - Desmoplastic fibroma of bone - Fibro-osseous tumour of bone NOS - Fibrosarcomatous dermatofibrosarcoma protuberans - Giant cell fibroblastoma - Infantile fibrosarcoma - Inflammatory myofibroblastic tumour - Intermediate risk solitary fibrous tumour - Lipofibromatosis - Low grade myofibroblastic sarcoma - Low risk solitary fibrous tumour - Myxoinflammatory fibroblastic sarcoma - NTRK-rearranged spindle cell neoplasm - Palmar/plantar fibromatosis - Superficial CD34-positive fibroblastic tumour - Intermediate fibrohistiocytic tumours - Giant cell tumour of bone - Giant cell tumour of soft tissues - Metastatic giant cell tumour of bone - Osseous tumour rich in giant cell NOS - Plexiform fibrohistiocytic tumour - Suspicion of giant cell tumour of bone - Intermediate osteogenic tumours - Osteoblastoma NOS - Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma) - Intermediate peripheral nerve sheath tumour - Malignant melanotic neural tumour - Intermediate tumours of uncertain differentiation - Aneurysmal bone cyst - Angiomatoid fibrous histiocytoma - Atypical fibroxanthoma - Cutaneous pleomorphic sarcoma - Hemosiderotic fibrolipomatous tumour - Lymphangioleiomyoma/lymphangioleiomyomatosis - Malignant phosphaturic mesenchymal tumour - Melanotic neuroectodermal tumour of infancy - Mesenchymal tumor with GLI1 alteration - Mixed tumour - Myoepithelioma - Ossifying fibromyxoid tumour - PECOMA - NOS - Phosphaturic mesenchymal tumour NOS - Intermediate vascular tumours - Composite hemangioendothelioma - Epithelioid vascular tumour of bone NOS - Kaposi sarcoma - Kaposiform hemangioendothelioma - Papillary intralymphatic angioendothelioma - Pseudomyogenic hemangioendothelioma - Retiform hemangioendothelioma - Other tumours of intermediate malignancy - Atypical smooth muscle tumour - EBV-associated smooth muscle tumour (STUMP) - Endometrial stromal nodule - Endometrial stromal tumor low-grade - Inflammatory rhabdomyoblastic tumour - Metastatic leiomyoma - Smooth muscle tumour of undetermined malignant potential (STUMP) - Uterine tumour resembling ovarian sex cord tumours (UTROSCT) - Other intermediate mesenchymal tumour of bone - Osteofibrous dysplasia-like adamantinoma - Mesenchymoma NOS

RC Diagnosis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Diagnosis made by the pathologist in the Regional Center
Possible values : - Benign lesion - Benign adipocytic tumours - Angiolipoma - Angiomyolipoma - Chondroid lipoma - Hibernoma - Lipoblastoma/lipoblastomatosis - Lipoma - Lipomatosis - Lipomatosis of nerve - Atypical spindle cell/pleomorphic lipomatous tumour - Myelolipoma - Myolipoma - Spindle cell / pleomorphic lipoma - Benign chondrogenic tumours - Chondroblastoma NOS - Chondroma - Chondromyxoid fibroma - Enchondroma - Osteochondroma - Osteochondromyxoma - Periosteal chondroma - Pulmonary chondroma - Pulmonary hamartoma - Subungueal exostosis - Synovial chondromatosis - Benign fibroblastic/myofibroblastic tumours - Adenofibroma - Angiofibroma - Angiomyofibroblastoma - Calcifying aponeurotic fibroma - Calcifying fibrous tumour - Cellular angiofibroma - Desmoplastic fibroblastoma - Elastofibroma - Fasciitis - Fibroblastic tumour with SMAD3 fusion - Fibrochondromyxoid tumour with THBS1 fusion - Fibro-osseous pseudotumour of digits - Fibroma of tendon sheath - Fibromatosis colli - Fibrous hamartoma of infancy - Gardner fibroma - Inclusion body fibromatosis - Intra-nodal palisaded myofibroblastoma - Ischaemic fasciitis - Juvenile hyaline fibromatosis - Myofibroblastoma - Myositis ossificans - Nasopharyngeal angiofibroma - Nodular fasciitis - Nuchal-type fibroma - Organ-associated pseudosarcomatous myofibroblastic proliferations - Other fibromas - Proliferative fasciitis - Proliferative myositis - Benign fibro-histiocytic tumours - Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws) - Deep benign fibrous histiocytoma - Epithelioid fibrous histiocytoma - Erdheim-Chester disease - Fibrous histiocytoma - Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma) - Langerhans cell histiocytosis - Non Ossifying fibroma - Rosai-Dorfman disease - Tenosynovial giant cell tumour NOS - Tenosynovial giant cell tumour, diffuse type - Tenosynovial giant cell tumour, localized type - Benign nerve sheath tumours - Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP - Benign Triton tumour - Dermal nerve sheath myxoma - Ectopic meningioma - Granular cell tumour - Hybrid nerve sheath tumours - Nasal glial heterotopia - Neurofibroma - Neurothekeoma - Perineurioma - Plexiform neurofibroma - Schwannoma - Solitary circumscribed neuroma - Benign notochordal tumour - Benign osteogenic tumours - Osteoid osteoma - Osteoma - Benign pericytic tumours - Angioleiomyoma - Glomus tumour - Myofibroma / myofibromatosis - Myopericytoma - Benign skeletal muscle tumours - Rhabdomyoma - Rhabdomyoma - adult type - Rhabdomyoma - fetal type - Rhabdomyoma - genital type - Benign smooth muscle tumours - Adenomyoma - Atypical polypoid adenomyoma - Bizarre nuclei leiomyoma - Cellular leiomyoma - Diffuse leiomyomatosis - Dissecans leiomyoma - Epithelioid leiomyoma - Intraveinous leiomyomatosis - Leiomyoma - Leiomyomatosis peritonealis disseminata - Mitotically-active leiomyoma - Myxoid leiomyoma - Benign tumours of uncertain differentiation - Acral fibromyxoma - Brown tumour - Deep (aggressive) angiomyxoma - Ectopic hamartomatous thymoma - Fibrous dysplasia - Inflammatory fibroid polyp - Intramuscular myxoma - Myxoma NOS - Osteofibrous dysplasia - Pleomorphic hyalinizing angiectatic tumour - Pleuropulmonary blastoma - Simple bone cyst - Superficial angiomyxoma - Benign vascular tumours - Angiolymphoid hyperplasia - Angiomatosis - Atypical vascular lesion - Diffuse pulmonary lymphangiomatosis - Epithelioid hemangioma - Gorham disease - Hemangioma - Intra-muscular hemangioma - Lymphangioma NOS - Lymphangiomatosis - Pyogenic granuloma - Osseous pseudo-tumours - Bizarre parosteal osteochondromatous proliferation - Callus - Florid ossificans periostitis - Post-traumatic fibro-osseous lesion - Tophaceous pseudogout - Other benign lesion - GIST - gastrointestinal stromal tumour (GIST), low, very low risk - gastrointestinal stromal tumour (GIST), intermediate risk - gastrointestinal stromal tumour (GIST), high risk - Non-mesenchymal malignant tumour - Carcinoma - Germinal tumor - Lymphoma - Melanoma - Myeloma - Other non-mesenchymal malignant tumours - Plasmocytoma - Other diagnoses - Diagnosis unspecified - Undifferentiated malignant tumour - Sarcoma - Chondrosarcoma - Central chondrosarcoma - Chondrosarcoma, grade 1 - Chondrosarcoma, grade 2 - Chondrosarcoma, grade 3 - Chondrosarcoma NOS - Clear cell chondrosarcoma - Dedifferentiated chondrosarcoma - Mesenchymal chondrosarcoma - Periosteal chondrosarcoma - Peripheral chondrosarcoma - Leiomyosarcoma - Leiomyosarcoma - differentiated - Leiomyosarcoma - epithelioid - Leiomyosarcoma - myxoid - Leiomyosarcoma - poorly-differentiated - Liposarcoma - Liposarcoma - dedifferentiated - Liposarcoma - mixed type - Liposarcoma - myxoid - Liposarcoma - NOS - Liposarcoma - pleomorphic - Liposarcoma - round cell - Liposarcoma - well differentiated - Myxoid pleomorphic liposarcoma - Malignant fibrohistiocytic tumours of bone - Malignant giant cell tumour of bone - Malignant peripheral nerve sheath tumour - Ectomesenchymoma - Malignant perineurioma - Malignant Triton tumour - MPNST - epithelioid type - MPNST - usual type - Miscellaneous sarcomas - Alveolar soft part sarcoma - Angiosarcoma - BCOR sarcoma - CIC-DUX sarcoma - CIC-rearranged sarcoma - Clear cell sarcoma - Desmoplastic round cell tumour - Epithelioid hemangioendothelioma NOS - Epithelioid hemangioendothelioma with TFE3 fusion - Epithelioid hemangioendothelioma with WWTR1 fusion - Epithelioid sarcoma - Ewing sarcoma - Extraskeletal myxoid chondrosarcoma - Fibrosarcoma NOS - High risk solitary fibrous tumour - Intimal sarcoma - Low grade fibromyxoid sarcoma - Low grade sinonasal sarcoma - Malignant glomus tumour - Malignant granular cell tumour - Malignant mesenchymoma - Malignant mixed tumor - Malignant myoepithelial tumour - Malignant ossifying fibromyxoid tumour - Malignant PECOMA - Malignant rhabdoid tumour - Malignant tenosynovial giant cell tumour - Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion - Sclerosing epithelioid fibrosarcoma - SMARCA4-deficient undifferentiated thoracic tumour - Myxofibrosarcoma - Osteosarcoma - Conventional osteosarcoma - Dedifferentiated low-grade central osteosarcoma - Dedifferentiated parosteal osteosarcoma - Extraskeletal osteosarcoma - High-grade surface osteosarcoma - Low-grade central osteosarcoma - Osteoblastoma-like osteosarcoma - Osteosarcoma NOS - Parosteal osteosarcoma - Periosteal osteosarcoma - Small cell osteosarcoma - Secondary osteosarcoma - Telangiectasic osteosarcoma - Other sarcomas - Adamantinoma - Adenosarcoma - Chondroid chordoma - Chordoma NOS - Dedifferentiated adamantimoma - Dedifferentiated chordoma - Endometrial stromal sarcoma - Endometrial stromal sarcoma - high-grade - Endometrial stromal sarcoma - low-grade - Phyllodes sarcoma - Undifferentiated uterine sarcoma - Poorly differenciated chordoma - Rhabdomyosarcoma - Adult spindle cell rhabdomyosarcoma - Alveolar rhabdomyosarcoma - Embryonal rhabdomyosarcoma - botryoid type - Embryonal rhabdomyosarcoma - NOS - Embryonal rhabdomyosarcoma - spindle cell type - Embryonal rhabdomyosarcoma - usual type - Pleomorphic rhabdomyosarcoma - Rhabdomyosarcoma - NOS - Rhabdomyosarcoma with MYOD1 mutation - Rhabdomyosarcoma with TFCP2 fusion - Rhabdomyosarcoma with VGLL2/NCOA2 fusion - Sclerosing rhabdomyosarcoma - Spindle cell rhabdomyosarcoma - Suspicion of sarcoma - Synovial sarcoma - Synovial sarcoma - biphasic - Synovial sarcoma - monophasic - Synovial sarcoma - NOS - Synovial sarcoma - poorly differentiated - Undifferentiated sarcoma - Undifferentiated epithelioid sarcoma - Undifferentiated pleomorphic sarcoma - Undifferentiated round cell sarcoma - Undifferentiated sarcoma - NOS - Undifferentiated spindle cell sarcoma - Tumour of intermediate malignancy - Atypical lipomatous tumour - Intermediate chondrogenic tumours - Atypical cartilaginous tumour - Cartilaginous tumour of uncertain prognosis - Chondromatosis NOS - Intermediate fibroblastic/myofibroblastic tumours - Dermatofibrosarcoma protuberans - Desmoid-type fibromatosis - Desmoplastic fibroma of bone - Fibro-osseous tumour of bone NOS - Fibrosarcomatous dermatofibrosarcoma protuberans - Giant cell fibroblastoma - Infantile fibrosarcoma - Inflammatory myofibroblastic tumour - Intermediate risk solitary fibrous tumour - Lipofibromatosis - Low grade myofibroblastic sarcoma - Low risk solitary fibrous tumour - Myxoinflammatory fibroblastic sarcoma - NTRK-rearranged spindle cell neoplasm - Palmar/plantar fibromatosis - Superficial CD34-positive fibroblastic tumour - Intermediate fibrohistiocytic tumours - Giant cell tumour of bone - Giant cell tumour of soft tissues - Metastatic giant cell tumour of bone - Osseous tumour rich in giant cell NOS - Plexiform fibrohistiocytic tumour - Suspicion of giant cell tumour of bone - Intermediate osteogenic tumours - Osteoblastoma NOS - Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma) - Intermediate peripheral nerve sheath tumour - Malignant melanotic neural tumour - Intermediate tumours of uncertain differentiation - Aneurysmal bone cyst - Angiomatoid fibrous histiocytoma - Atypical fibroxanthoma - Cutaneous pleomorphic sarcoma - Hemosiderotic fibrolipomatous tumour - Lymphangioleiomyoma/lymphangioleiomyomatosis - Malignant phosphaturic mesenchymal tumour - Melanotic neuroectodermal tumour of infancy - Mesenchymal tumor with GLI1 alteration - Mixed tumour - Myoepithelioma - Ossifying fibromyxoid tumour - PECOMA - NOS - Phosphaturic mesenchymal tumour NOS - Intermediate vascular tumours - Composite hemangioendothelioma - Epithelioid vascular tumour of bone NOS - Kaposi sarcoma - Kaposiform hemangioendothelioma - Papillary intralymphatic angioendothelioma - Pseudomyogenic hemangioendothelioma - Retiform hemangioendothelioma - Other tumours of intermediate malignancy - Atypical smooth muscle tumour - EBV-associated smooth muscle tumour (STUMP) - Endometrial stromal nodule - Endometrial stromal tumor low-grade - Inflammatory rhabdomyoblastic tumour - Metastatic leiomyoma - Smooth muscle tumour of undetermined malignant potential (STUMP) - Uterine tumour resembling ovarian sex cord tumours (UTROSCT) - Other intermediate mesenchymal tumour of bone - Mesenchymoma NOS - Osteofibrous dysplasia-like adamantinoma

NC Diagnosis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Diagnosis made by the pathologist in the National Center
Possible values : - Benign lesion - Benign adipocytic tumours - Angiolipoma - Angiomyolipoma - Chondroid lipoma - Hibernoma - Lipoblastoma/lipoblastomatosis - Lipoma - Lipomatosis - Lipomatosis of nerve - Atypical spindle cell/pleomorphic lipomatous tumour - Myelolipoma - Myolipoma - Spindle cell / pleomorphic lipoma - Benign chondrogenic tumours - Chondroblastoma NOS - Chondroma - Chondromyxoid fibroma - Enchondroma - Osteochondroma - Osteochondromyxoma - Periosteal chondroma - Pulmonary chondroma - Pulmonary hamartoma - Subungueal exostosis - Synovial chondromatosis - Benign fibroblastic/myofibroblastic tumours - Adenofibroma - Angiofibroma - Angiomyofibroblastoma - Calcifying aponeurotic fibroma - Calcifying fibrous tumour - Cellular angiofibroma - Desmoplastic fibroblastoma - Elastofibroma - Fasciitis - Fibroblastic tumour with SMAD3 fusion - Fibrochondromyxoid tumour with THBS1 fusion - Fibro-osseous pseudotumour of digits - Fibroma of tendon sheath - Fibromatosis colli - Fibrous hamartoma of infancy - Gardner fibroma - Inclusion body fibromatosis - Intra-nodal palisaded myofibroblastoma - Ischaemic fasciitis - Juvenile hyaline fibromatosis - Myofibroblastoma - Myositis ossificans - Nasopharyngeal angiofibroma - Nodular fasciitis - Nuchal-type fibroma - Organ-associated pseudosarcomatous myofibroblastic proliferations - Other fibromas - Proliferative fasciitis - Proliferative myositis - Benign fibro-histiocytic tumours - Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws) - Deep benign fibrous histiocytoma - Epithelioid fibrous histiocytoma - Erdheim-Chester disease - Fibrous histiocytoma - Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma) - Langerhans cell histiocytosis - Non Ossifying fibroma - Rosai-Dorfman disease - Tenosynovial giant cell tumour NOS - Tenosynovial giant cell tumour, diffuse type - Tenosynovial giant cell tumour, localized type - Benign nerve sheath tumours - Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP - Benign Triton tumour - Dermal nerve sheath myxoma - Ectopic meningioma - Granular cell tumour - Hybrid nerve sheath tumours - Nasal glial heterotopia - Neurofibroma - Neurothekeoma - Perineurioma - Plexiform neurofibroma - Schwannoma - Solitary circumscribed neuroma - Benign notochordal tumour - Benign osteogenic tumours - Osteoid osteoma - Osteoma - Benign pericytic tumours - Angioleiomyoma - Glomus tumour - Myofibroma / myofibromatosis - Myopericytoma - Benign skeletal muscle tumours - Rhabdomyoma - Rhabdomyoma - adult type - Rhabdomyoma - fetal type - Rhabdomyoma - genital type - Benign smooth muscle tumours - Adenomyoma - Atypical polypoid adenomyoma - Bizarre nuclei leiomyoma - Cellular leiomyoma - Diffuse leiomyomatosis - Dissecans leiomyoma - Epithelioid leiomyoma - Intraveinous leiomyomatosis - Leiomyoma - Leiomyomatosis peritonealis disseminata - Mitotically-active leiomyoma - Myxoid leiomyoma - Benign tumours of uncertain differentiation - Acral fibromyxoma - Brown tumour - Deep (aggressive) angiomyxoma - Ectopic hamartomatous thymoma - Fibrous dysplasia - Inflammatory fibroid polyp - Intramuscular myxoma - Myxoma NOS - Osteofibrous dysplasia - Pleomorphic hyalinizing angiectatic tumour - Pleuropulmonary blastoma - Simple bone cyst - Superficial angiomyxoma - Benign vascular tumours - Angiolymphoid hyperplasia - Angiomatosis - Atypical vascular lesion - Diffuse pulmonary lymphangiomatosis - Epithelioid hemangioma - Gorham disease - Hemangioma - Intra-muscular hemangioma - Lymphangioma NOS - Lymphangiomatosis - Pyogenic granuloma - Osseous pseudo-tumours - Bizarre parosteal osteochondromatous proliferation - Callus - Florid ossificans periostitis - Post-traumatic fibro-osseous lesion - Tophaceous pseudogout - Other benign lesion - GIST - gastrointestinal stromal tumour (GIST), low, very low risk - gastrointestinal stromal tumour (GIST), intermediate risk - gastrointestinal stromal tumour (GIST), high risk - Non-mesenchymal malignant tumour - Carcinoma - Germinal tumor - Lymphoma - Melanoma - Myeloma - Other non-mesenchymal malignant tumours - Plasmocytoma - Other diagnoses - Undifferentiated malignant tumour - Diagnosis unspecified - Sarcoma - Chondrosarcoma - Central chondrosarcoma - Chondrosarcoma, grade 1 - Chondrosarcoma, grade 2 - Chondrosarcoma, grade 3 - Chondrosarcoma NOS - Clear cell chondrosarcoma - Dedifferentiated chondrosarcoma - Mesenchymal chondrosarcoma - Periosteal chondrosarcoma - Peripheral chondrosarcoma - Leiomyosarcoma - Leiomyosarcoma - differentiated - Leiomyosarcoma - epithelioid - Leiomyosarcoma - myxoid - Leiomyosarcoma - poorly-differentiated - Liposarcoma - Liposarcoma - dedifferentiated - Liposarcoma - mixed type - Liposarcoma - myxoid - Liposarcoma - NOS - Liposarcoma - pleomorphic - Liposarcoma - round cell - Liposarcoma - well differentiated - Myxoid pleomorphic liposarcoma - Malignant fibrohistiocytic tumours of bone - Malignant giant cell tumour of bone - Malignant peripheral nerve sheath tumour - Ectomesenchymoma - Malignant perineurioma - Malignant Triton tumour - MPNST - epithelioid type - MPNST - usual type - Miscellaneous sarcomas - Alveolar soft part sarcoma - Angiosarcoma - BCOR sarcoma - CIC-DUX sarcoma - CIC-rearranged sarcoma - Clear cell sarcoma - Desmoplastic round cell tumour - Epithelioid hemangioendothelioma NOS - Epithelioid hemangioendothelioma with TFE3 fusion - Epithelioid hemangioendothelioma with WWTR1 fusion - Epithelioid sarcoma - Ewing sarcoma - Extraskeletal myxoid chondrosarcoma - Fibrosarcoma NOS - High risk solitary fibrous tumour - Intimal sarcoma - Low grade fibromyxoid sarcoma - Low grade sinonasal sarcoma - Malignant glomus tumour - Malignant granular cell tumour - Malignant mesenchymoma - Malignant mixed tumor - Malignant myoepithelial tumour - Malignant ossifying fibromyxoid tumour - Malignant PECOMA - Malignant rhabdoid tumour - Malignant tenosynovial giant cell tumour - Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion - Sclerosing epithelioid fibrosarcoma - SMARCA4-deficient undifferentiated thoracic tumour - Myxofibrosarcoma - Osteosarcoma - Conventional osteosarcoma - Dedifferentiated low-grade central osteosarcoma - Dedifferentiated parosteal osteosarcoma - Extraskeletal osteosarcoma - High-grade surface osteosarcoma - Low-grade central osteosarcoma - Osteoblastoma-like osteosarcoma - Osteosarcoma NOS - Parosteal osteosarcoma - Periosteal osteosarcoma - Small cell osteosarcoma - Secondary osteosarcoma - Telangiectasic osteosarcoma - Other sarcomas - Adamantinoma - Adenosarcoma - Chondroid chordoma - Chordoma NOS - Dedifferentiated adamantimoma - Dedifferentiated chordoma - Endometrial stromal sarcoma - Endometrial stromal sarcoma - high-grade - Endometrial stromal sarcoma - low-grade - Phyllodes sarcoma - Poorly differenciated chordoma - Undifferentiated uterine sarcoma - Rhabdomyosarcoma - Adult spindle cell rhabdomyosarcoma - Alveolar rhabdomyosarcoma - Embryonal rhabdomyosarcoma - botryoid type - Embryonal rhabdomyosarcoma - NOS - Embryonal rhabdomyosarcoma - spindle cell type - Embryonal rhabdomyosarcoma - usual type - Pleomorphic rhabdomyosarcoma - Rhabdomyosarcoma - NOS - Rhabdomyosarcoma with MYOD1 mutation - Rhabdomyosarcoma with TFCP2 fusion - Rhabdomyosarcoma with VGLL2/NCOA2 fusion - Sclerosing rhabdomyosarcoma - Spindle cell rhabdomyosarcoma - Suspicion of sarcoma - Synovial sarcoma - Synovial sarcoma - biphasic - Synovial sarcoma - monophasic - Synovial sarcoma - NOS - Synovial sarcoma - poorly differentiated - Undifferentiated sarcoma - Undifferentiated epithelioid sarcoma - Undifferentiated pleomorphic sarcoma - Undifferentiated round cell sarcoma - Undifferentiated sarcoma - NOS - Undifferentiated spindle cell sarcoma - Tumour of intermediate malignancy - Atypical lipomatous tumour - Intermediate chondrogenic tumours - Atypical cartilaginous tumour - Cartilaginous tumour of uncertain prognosis - Chondromatosis NOS - Intermediate fibroblastic/myofibroblastic tumours - Dermatofibrosarcoma protuberans - Desmoid-type fibromatosis - Desmoplastic fibroma of bone - Fibro-osseous tumour of bone NOS - Fibrosarcomatous dermatofibrosarcoma protuberans - Giant cell fibroblastoma - Infantile fibrosarcoma - Inflammatory myofibroblastic tumour - Intermediate risk solitary fibrous tumour - Lipofibromatosis - Low grade myofibroblastic sarcoma - Low risk solitary fibrous tumour - Myxoinflammatory fibroblastic sarcoma - NTRK-rearranged spindle cell neoplasm - Palmar/plantar fibromatosis - Superficial CD34-positive fibroblastic tumour - Intermediate fibrohistiocytic tumours - Giant cell tumour of bone - Giant cell tumour of soft tissues - Metastatic giant cell tumour of bone - Osseous tumour rich in giant cell NOS - Plexiform fibrohistiocytic tumour - Suspicion of giant cell tumour of bone - Intermediate osteogenic tumours - Osteoblastoma NOS - Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma) - Intermediate peripheral nerve sheath tumour - Malignant melanotic neural tumour - Intermediate tumours of uncertain differentiation - Aneurysmal bone cyst - Angiomatoid fibrous histiocytoma - Atypical fibroxanthoma - Cutaneous pleomorphic sarcoma - Hemosiderotic fibrolipomatous tumour - Lymphangioleiomyoma/lymphangioleiomyomatosis - Malignant phosphaturic mesenchymal tumour - Melanotic neuroectodermal tumour of infancy - Mesenchymal tumor with GLI1 alteration - Mixed tumour - Myoepithelioma - Ossifying fibromyxoid tumour - PECOMA - NOS - Phosphaturic mesenchymal tumour NOS - Intermediate vascular tumours - Composite hemangioendothelioma - Epithelioid vascular tumour of bone NOS - Kaposi sarcoma - Kaposiform hemangioendothelioma - Papillary intralymphatic angioendothelioma - Pseudomyogenic hemangioendothelioma - Retiform hemangioendothelioma - Other tumours of intermediate malignancy - Atypical smooth muscle tumour - EBV-associated smooth muscle tumour (STUMP) - Endometrial stromal nodule - Endometrial stromal tumor low-grade - Inflammatory rhabdomyoblastic tumour - Metastatic leiomyoma - Smooth muscle tumour of undetermined malignant potential (STUMP) - Uterine tumour resembling ovarian sex cord tumours (UTROSCT) - Other intermediate mesenchymal tumour of bone - Mesenchymoma NOS - Osteofibrous dysplasia-like adamantinoma

Type of resection
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Monobloc: sample removed in one pieceFragmented: sample removed in several pieces
Possible values : Monobloc, Fragmented, Unknown

Grade (ACP)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : ACP grade
Possible values : 1, 2, 3, Not applicable, Not done

Grade (RC)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Tumour Grade observed by the expert pathologist in the Regional Center
Possible values : 1, 2, 3, Not applicable, Not done

Grade (NC)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Tumour Grade observed by the expert pathologist in the National Center
Possible values : 1, 2, 3, Not applicable, Not done

Meeting requester
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : The pathologist name who presented the sample
Possible values : - Coordinator site - TOURS Trousseau - CLB - Institut Bergonié - IGR - Reference Center - ANGERS - BORDEAUX - LILLE - LYON - MARSEILLE - NANCY - NANTES - PARIS Cochin - PARIS centre Huguenin - STRASBOURG - TOULOUSE - TOURS - Contributing center - CAEN - PARIS Trousseau - RENNES - ROUEN

Date of meeting
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of the national reviewing

Meeting diagnosis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Diagnosis reviewed by several experts pathologists during the national reviewing
Possible values : - Benign lesion - Benign adipocytic tumours - Angiolipoma - Angiomyolipoma - Chondroid lipoma - Hibernoma - Lipoblastoma/lipoblastomatosis - Lipoma - Lipomatosis - Lipomatosis of nerve - Myelolipoma - Atypical spindle cell/pleomorphic lipomatous tumour - Myolipoma - Spindle cell / pleomorphic lipoma - Benign chondrogenic tumours - Chondroblastoma NOS - Chondroma - Chondromyxoid fibroma - Enchondroma - Osteochondroma - Osteochondromyxoma - Periosteal chondroma - Pulmonary chondroma - Pulmonary hamartoma - Subungueal exostosis - Synovial chondromatosis - Benign fibroblastic/myofibroblastic tumours - Adenofibroma - Angiofibroma - Angiomyofibroblastoma - Calcifying aponeurotic fibroma - Calcifying fibrous tumour - Cellular angiofibroma - Desmoplastic fibroblastoma - Elastofibroma - Fasciitis - Fibroblastic tumour with SMAD3 fusion - Fibrochondromyxoid tumour with THBS1 fusion - Fibro-osseous pseudotumour of digits - Fibroma of tendon sheath - Fibromatosis colli - Fibrous hamartoma of infancy - Gardner fibroma - Inclusion body fibromatosis - Intra-nodal palisaded myofibroblastoma - Ischaemic fasciitis - Juvenile hyaline fibromatosis - Myofibroblastoma - Myositis ossificans - Nasopharyngeal angiofibroma - Nodular fasciitis - Nuchal-type fibroma - Organ-associated pseudosarcomatous myofibroblastic proliferations - Other fibromas - Proliferative fasciitis - Proliferative myositis - Benign fibro-histiocytic tumours - Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws) - Deep benign fibrous histiocytoma - Epithelioid fibrous histiocytoma - Erdheim-Chester disease - Fibrous histiocytoma - Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma) - Langerhans cell histiocytosis - Non Ossifying fibroma - Rosai-Dorfman disease - Tenosynovial giant cell tumour NOS - Tenosynovial giant cell tumour, diffuse type - Tenosynovial giant cell tumour, localized type - Benign nerve sheath tumours - Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP - Benign Triton tumour - Dermal nerve sheath myxoma - Ectopic meningioma - Granular cell tumour - Hybrid nerve sheath tumours - Nasal glial heterotopia - Neurofibroma - Neurothekeoma - Perineurioma - Plexiform neurofibroma - Schwannoma - Solitary circumscribed neuroma - Benign notochordal tumour - Benign osteogenic tumours - Osteoid osteoma - Osteoma - Benign pericytic tumours - Angioleiomyoma - Glomus tumour - Myofibroma / myofibromatosis - Myopericytoma - Benign skeletal muscle tumours - Rhabdomyoma - Rhabdomyoma - adult type - Rhabdomyoma - fetal type - Rhabdomyoma - genital type - Benign smooth muscle tumours - Adenomyoma - Atypical polypoid adenomyoma - Bizarre nuclei leiomyoma - Cellular leiomyoma - Diffuse leiomyomatosis - Dissecans leiomyoma - Epithelioid leiomyoma - Intraveinous leiomyomatosis - Leiomyoma - Leiomyomatosis peritonealis disseminata - Mitotically-active leiomyoma - Myxoid leiomyoma - Benign tumours of uncertain differentiation - Acral fibromyxoma - Brown tumour - Deep (aggressive) angiomyxoma - Ectopic hamartomatous thymoma - Fibrous dysplasia - Inflammatory fibroid polyp - Intramuscular myxoma - Myxoma NOS - Osteofibrous dysplasia - Pleomorphic hyalinizing angiectatic tumour - Pleuropulmonary blastoma - Simple bone cyst - Superficial angiomyxoma - Benign vascular tumours - Angiolymphoid hyperplasia - Angiomatosis - Atypical vascular lesion - Diffuse pulmonary lymphangiomatosis - Epithelioid hemangioma - Gorham disease - Hemangioma - Intra-muscular hemangioma - Lymphangioma NOS - Lymphangiomatosis - Pyogenic granuloma - Osseous pseudo-tumours - Bizarre parosteal osteochondromatous proliferation - Callus - Florid ossificans periostitis - Post-traumatic fibro-osseous lesion - Tophaceous pseudogout - Other benign lesion - GIST - gastrointestinal stromal tumour (GIST), low, very low risk - gastrointestinal stromal tumour (GIST), intermediate risk - gastrointestinal stromal tumour (GIST), high risk - Non-mesenchymal malignant tumour - Carcinoma - Germinal tumor - Lymphoma - Melanoma - Myeloma - Other non-mesenchymal malignant tumours - Plasmocytoma - Other diagnoses - Diagnosis unspecified - Undifferentiated malignant tumour - Sarcoma - Chondrosarcoma - Central chondrosarcoma - Chondrosarcoma, grade 1 - Chondrosarcoma, grade 2 - Chondrosarcoma, grade 3 - Chondrosarcoma NOS - Clear cell chondrosarcoma - Dedifferentiated chondrosarcoma - Mesenchymal chondrosarcoma - Periosteal chondrosarcoma - Peripheral chondrosarcoma - Leiomyosarcoma - Leiomyosarcoma - differentiated - Leiomyosarcoma - epithelioid - Leiomyosarcoma - myxoid - Leiomyosarcoma - poorly-differentiated - Liposarcoma - Liposarcoma - dedifferentiated - Liposarcoma - mixed type - Liposarcoma - myxoid - Liposarcoma - NOS - Liposarcoma - pleomorphic - Liposarcoma - round cell - Liposarcoma - well differentiated - Myxoid pleomorphic liposarcoma - Malignant fibrohistiocytic tumours of bone - Malignant giant cell tumour of bone - Malignant peripheral nerve sheath tumour - Ectomesenchymoma - Malignant perineurioma - Malignant Triton tumour - MPNST - epithelioid type - MPNST - usual type - Miscellaneous sarcomas - Alveolar soft part sarcoma - Angiosarcoma - BCOR sarcoma - CIC-DUX sarcoma - CIC-rearranged sarcoma - Clear cell sarcoma - Desmoplastic round cell tumour - Epithelioid hemangioendothelioma NOS - Epithelioid hemangioendothelioma with TFE3 fusion - Epithelioid hemangioendothelioma with WWTR1 fusion - Epithelioid sarcoma - Ewing sarcoma - Extraskeletal myxoid chondrosarcoma - Fibrosarcoma NOS - High risk solitary fibrous tumour - Intimal sarcoma - Low grade fibromyxoid sarcoma - Low grade sinonasal sarcoma - Malignant glomus tumour - Malignant granular cell tumour - Malignant mesenchymoma - Malignant mixed tumor - Malignant myoepithelial tumour - Malignant ossifying fibromyxoid tumour - Malignant PECOMA - Malignant rhabdoid tumour - Malignant tenosynovial giant cell tumour - Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion - Sclerosing epithelioid fibrosarcoma - SMARCA4-deficient undifferentiated thoracic tumour - Myxofibrosarcoma - Osteosarcoma - Conventional osteosarcoma - Dedifferentiated low-grade central osteosarcoma - Dedifferentiated parosteal osteosarcoma - Extraskeletal osteosarcoma - High-grade surface osteosarcoma - Low-grade central osteosarcoma - Osteoblastoma-like osteosarcoma - Osteosarcoma NOS - Parosteal osteosarcoma - Periosteal osteosarcoma - Small cell osteosarcoma - Secondary osteosarcoma - Telangiectasic osteosarcoma - Other sarcomas - Adamantinoma - Adenosarcoma - Chondroid chordoma - Chordoma NOS - Dedifferentiated adamantimoma - Dedifferentiated chordoma - Endometrial stromal sarcoma - Endometrial stromal sarcoma - high-grade - Endometrial stromal sarcoma - low-grade - Phyllodes sarcoma - Poorly differenciated chordoma - Undifferentiated uterine sarcoma - Rhabdomyosarcoma - Adult spindle cell rhabdomyosarcoma - Alveolar rhabdomyosarcoma - Embryonal rhabdomyosarcoma - botryoid type - Embryonal rhabdomyosarcoma - NOS - Embryonal rhabdomyosarcoma - spindle cell type - Embryonal rhabdomyosarcoma - usual type - Pleomorphic rhabdomyosarcoma - Rhabdomyosarcoma - NOS - Rhabdomyosarcoma with MYOD1 mutation - Rhabdomyosarcoma with TFCP2 fusion - Rhabdomyosarcoma with VGLL2/NCOA2 fusion - Sclerosing rhabdomyosarcoma - Spindle cell rhabdomyosarcoma - Suspicion of sarcoma - Synovial sarcoma - Synovial sarcoma - biphasic - Synovial sarcoma - monophasic - Synovial sarcoma - NOS - Synovial sarcoma - poorly differentiated - Undifferentiated sarcoma - Undifferentiated epithelioid sarcoma - Undifferentiated pleomorphic sarcoma - Undifferentiated round cell sarcoma - Undifferentiated sarcoma - NOS - Undifferentiated spindle cell sarcoma - Tumour of intermediate malignancy - Atypical lipomatous tumour - Intermediate chondrogenic tumours - Atypical cartilaginous tumour - Cartilaginous tumour of uncertain prognosis - Chondromatosis NOS - Intermediate fibroblastic/myofibroblastic tumours - Dermatofibrosarcoma protuberans - Desmoid-type fibromatosis - Desmoplastic fibroma of bone - Fibro-osseous tumour of bone NOS - Fibrosarcomatous dermatofibrosarcoma protuberans - Giant cell fibroblastoma - Infantile fibrosarcoma - Inflammatory myofibroblastic tumour - Intermediate risk solitary fibrous tumour - Lipofibromatosis - Low grade myofibroblastic sarcoma - Low risk solitary fibrous tumour - Myxoinflammatory fibroblastic sarcoma - NTRK-rearranged spindle cell neoplasm - Palmar/plantar fibromatosis - Superficial CD34-positive fibroblastic tumour - Intermediate fibrohistiocytic tumours - Giant cell tumour of soft tissues - Giant cell tumour of bone - Metastatic giant cell tumour of bone - Osseous tumour rich in giant cell NOS - Plexiform fibrohistiocytic tumour - Suspicion of giant cell tumour of bone - Intermediate osteogenic tumours - Osteoblastoma NOS - Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma) - Intermediate peripheral nerve sheath tumour - Malignant melanotic neural tumour - Intermediate tumours of uncertain differentiation - Aneurysmal bone cyst - Angiomatoid fibrous histiocytoma - Atypical fibroxanthoma - Cutaneous pleomorphic sarcoma - Hemosiderotic fibrolipomatous tumour - Lymphangioleiomyoma/lymphangioleiomyomatosis - Malignant phosphaturic mesenchymal tumour - Melanotic neuroectodermal tumour of infancy - Mesenchymal tumor with GLI1 alteration - Mixed tumour - Myoepithelioma - Ossifying fibromyxoid tumour - PECOMA - NOS - Phosphaturic mesenchymal tumour NOS - Intermediate vascular tumours - Composite hemangioendothelioma - Epithelioid vascular tumour of bone NOS - Kaposi sarcoma - Kaposiform hemangioendothelioma - Papillary intralymphatic angioendothelioma - Pseudomyogenic hemangioendothelioma - Retiform hemangioendothelioma - Other tumours of intermediate malignancy - Atypical smooth muscle tumour - EBV-associated smooth muscle tumour (STUMP) - Endometrial stromal nodule - Endometrial stromal tumor low-grade - Inflammatory rhabdomyoblastic tumour - Metastatic leiomyoma - Smooth muscle tumour of undetermined malignant potential (STUMP) - Uterine tumour resembling ovarian sex cord tumours (UTROSCT) - Other intermediate mesenchymal tumour of bone - Mesenchymoma NOS - Osteofibrous dysplasia-like adamantinoma

Meeting grade
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Grade reviewed by several experts pathologists during the national reviewing
Possible values : 1, 2, 3, Not applicable, Not done

Meeting tumour spillage
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Tumour spillage confirmed by several experts pathologists during the national reviewing
Possible values : Yes, No, Unknown

Tumour spillage (ACP)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Initial pathologist observed if the tumour was spilt
Possible values : Yes, No, Unknown

Tumour spillage (RC)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Regional Center pathologist observed if the tumour was spilt
Possible values : Yes, No, Unknown

Tumour spillage (NC)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : National Center pathologist observed if the tumour was spilt
Possible values : Yes, No, Unknown

RC Reviewer
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Pathologist in the Regional Center who reviewed the sample

NC Reviewer
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Pathologist in the National Center who reviewed the sample

Date 2 (RESOS)
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of the second presentation during the national reviewing

Date 3 (RESOS)
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of the thrid presentation during the national reviewing

Virtual slide
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

Frozen tissue
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

Paraffin available
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

Immunohistochemistry
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

FISH
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

Result FISH
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : In progress, Negative, Non interpretable, Positive

Molecular Biology
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Molecular Biology techniques performed
Possible values : No, Yes

Result (Molecular Biology)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : In progress, Negative, Positive, Non interpretable

ACP structure ID
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description :

Regional centre
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description :

National centre
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description :

RNASeq
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Not done, Done non interpretable, Done interpretable

Gene 1
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Fusion transcript gene 1
Possible values : No transcrit, Other, A2M, ABHD12B, AC011523.2, ACBD5, ACSL3, ACSL5, ACTB, ACTN1, ADGRF5, AFAP1, AFF3, AGBL4, AGK, AGTRAP, AHCYL1, AHRR, AKAP13, AKAP9, AKT3, ALK, AMACR, AP3S1, APIP, ARHGAP12, ARID1A, ARID1B, ASPSCR1, ATF1, ATG16L1, ATIC, ATP11B, ATP2B4, ATXN1, AUTS2, BAG4, BAIAP2L1, BCAN, BCAP29, BCL10, BCL2, BCLAF1, BCOR, BCORL1, BCR, BICC1, BIRC3, BMX, BRAF, BRD1, BRD3, BRD4, BRD8, BTBD1, C11orf95, C19MC, C3orf62, C5orf30, CAB39L, CAD, CALML4, CAMTA1, CANT1, CAPZA2, CARMN, CARS, CASP7, CCAR2, CCDC6, CCDC67, CCDC88C, CCNB3, CCND1, CCNH, CD101, CD44, CD63, CD74, CD99L2, CDC27, CDH11, CDH17, CDK5RAP2, CDX1, CEACAM5, CEP128, CEP192, CEP89, CHCHD7, CHD7, CIC, CIITA, CITED1, CITED2, CLCN6, CLDN1, CLIP1, CLIP2, CLN6, CLTC, CNNM3, COL12A1, COL17A1, COL1A, COL1A1, COL1A2, COL3A1, COL6A3, COMMD10, CPG, CPSF6, CREB1, CREB3L1, CREB3L2, CREB3L3, CREBBP, CREBZF, CREM, CRTC1, CRTC3, CSF1, CTB.35F21.1, CTNNA3, CTNNB1, CXCR4, CXorf67, DACH1, DAXX, DCTN1, DDIT3, DDX3X, DDX5, DIP2C, DKKL1, DNAH5, DNAJB6, DST, DTD1, DUS4L, DUX4, DUX4L2, E2F1, EEF1AKMT3, EGF, EGFR, EHBP1, EIF3E, ELF5, ELK4, ELN, EMILIN2, EML4, EMP1, EP300, EP400, EPC1, EPC2, EPS15, ERBB2, ERC1, ERG, ERLIN2, ESR1, ESRP1, EST14, ETV1, ETV2, ETV4, ETV5, ETV6, EWSR1, EZR, FAM131B, FAM227A, FER, FEV, FGF1, FGF2, FGFR1, FGFR2, FGFR3, FHIT, FIP1L1, FLI1, FLJ60017, FN1, FOSB, FOXO1, FOXO4, FOXO6, FOXP1, FOXR1, FUS, GCC2, GCNT3, GIT2, GLI1, GNAI1, GOLGA5, GOLGB1, GOPC, GPN1, GPS2, GREB1, GRIK2, GRM1, GSN, GTF2I, GTF3C2, GUCA2B, HAS2, HBA, HBA2, HBB, HENMT1, HERV-K, HERVK17, HEY1, HIP1, HIPK1, HLA-A, HMGA1, HMGA2, HMGN2P46, HNRNPA2B1, HOOK1, HOOK3, HOXD13, HS6ST2, HSPA8, HTN3, HTT, IG, IGF2, IGFBP5, IGH, IGK, IGL, IKBKG, INO80D, IRF2BP2, IRF4/DUSP22, ITD, JAK2, JAZF1, KANSL1, KAT6B, KCTD7, KDM2A, KDM2B, KDM4B, KHDRB52, KHSRP, KIAA1217, KIAA1549, KIAA1598, KIF5B, KIFC3, KIRREL, KLC1, KLF15, KLF17, KLHL29, KLHL7, KLK2, KMT2A, KRAS, KTN1, LACTB2, LAMTOR1, LIFR, LMAN2L, LMNA, LPP, LRIG3, LRRC31, LRRC34, LRRC59, LRRFIP1, LRRFIP2, LSM14A, LUC7L3, LYN, MAD1L1, MAGI3, MALAT1, MALT1, MAML2, MAML3, MAN2A1, MAP3K8, MBD1, MBTD1, MDK, MEAF6, MECOM, MED12, MEF2C, MEIS1, MELK, MET, MGA, MIPOL1, MIR143HG, MITF, MKL2, MKRN1, MLL, MLL4, MLPH, MPRIP, MSANTD3, MSN, MTOR, MXD1, MYB, MYBL1, MYC, MYH10, MYH9, MYO5A, NAB2, NACC2, NAV2, NCOA1, NCOA2, NCOA3, NCOA4, NCOR2, ND4, NDRG1, NF1, NFASC, NFATC1, NFATC2, NFIA, NFIB, NOL4L, NONO, NOS2, NOTCH1, NOTCH2, NOTCH3, NPC1, NPM1, NR4A3, NRG1, NSD3, NTRK1, NTRK2, NTRK3, NUDCD3, NUMA1, NUP160, NUP214, NUP98, NUTM1, NUTM2A, NUTM2B, NUTM2E, OFD1, OGDH, OMD, PAFAH1B2, PAN3, PAPSS1, PARP14, PATZ1, PAX3, PAX5, PAX7, PAX8, PBX1, PBX3, PDCD1LG2, PDE3B, PDE4DIP, PDE8A, PDGFB, PDGFD, PDGFRA, PDGFRB, PDHX, PDPN, PHF1, PIK3C2A, PITPNC1, PLA2G6, PLAG1, PLIN3, PML, POM121, POU1F1, POU3F1, POU5F1, PPAPDC1A, PPARG, PPFIBP1, PPL, PPP1R1B, PPP6R3, PRB3, PRCC, PRDM10, PRG4, PRKAR1A, PRKCA, PRKCB, PRKCD, PRKD1, PRKDC, PRKG1, PSD2, PSMA8, PTCH1, PTEN, PTMA, PTPRD, PTPRJ, PTPRK, PTPRZ1, PVT1, PWWP2A, QKI, RAB2A, RABGAP1L, RAD51, RAD51B, RAD52, RAF1, RANBP2, RARG, RBM10, RCC1, RELA, RET, RFWD2, RNF13, RNF130, RNF213, ROS1, RP11.57H14.3, RPLP1, RPS11, RRBP1, RREB1, RSPO2, RSPO3, RUNX1, S100A10, SCARB1, SCYL3, SDC4, SEC31A, SEC61G, SERINC1, SERPINE1, SET, SETBP1, SFMBT1, SFPQ, SHH, SLC11A2, SLC12A7, SLC16A7, SLC1A2, SLC26A11, SLC34A2, SLC3A2, SLC43A3, SLC45A2, SLC45A3, SLC5A11, SLC7A14, SMAD2, SMAD3, SMARCA4, SMARCA5, SNAPC3, SND1, SNX19, SOS1, SOX6, SP3, SPATA16, SPECC1L, SPTBN1, SQSTM1, SRF, SS18, SS18L1, SSX1, SSX2, SSX2B, SSX4, STARD3, STAT6, STK32B, STRN, SUZ12, SVIL, TACC1, TACC3, TAF15, TAX1BP1, TBL1XR1, TCEA1, TCF12, TCF4, TCF7L2, TEAD1, TENM4, TERT, TFCP2, TFE3, TFEB, TFG, TGFBR3, THBS1, THRAP3, TIMP3, TLN2, TMEM135, TMPRSS2, TNC, TNS3, TOM1L2, TOP2B, TP53, TP53BP1, TPM1, TPM3, TPM4, TPR, TPRG1, TPTEP1, TRA2B, TRIM11, TRIM24, TRIM27, TRIM33, TRIM4, TRIO, TRIT1, TRMT11, TSFM, TTC17, TTC28, TTYH1, UBE2L3, UBR5, ULK4, USP6, VCL, VGLL2, VGLL3, VGLL4, VIM, VMP1, VTI1A, WDR91, WHSC1L1, WIF1, WT1, WWTR1, YAP1, YWHAE, YY1, ZC3H7B, ZCCHC8, ZFP36, ZFPM2, ZKSCAN1, ZKSCAN5, ZMYM2, ZNF207, ZNF217, ZNF278, ZNF423, ZNF444, ZNF521, ZNF595, ZNF737, ZNF9

Unlisted gene 1
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Fusion transcript unlisted gene 1

Gene 2
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Fusion transcript gene 2
Possible values : No transcrit, Other, A2M, ABHD12B, AC011523.2, ACBD5, ACSL3, ACSL5, ACTB, ACTN1, ADGRF5, AFAP1, AFF3, AGBL4, AGK, AGTRAP, AHCYL1, AHRR, AKAP13, AKAP9, AKT3, ALK, AMACR, AP3S1, APIP, ARHGAP12, ARID1A, ARID1B, ASPSCR1, ATF1, ATG16L1, ATIC, ATP11B, ATP2B4, ATXN1, AUTS2, BAG4, BAIAP2L1, BCAN, BCAP29, BCL10, BCL2, BCLAF1, BCOR, BCORL1, BCR, BICC1, BIRC3, BMX, BRAF, BRD1, BRD3, BRD4, BRD8, BTBD1, C11orf95, C19MC, C3orf62, C5orf30, CAB39L, CAD, CALML4, CAMTA1, CANT1, CAPZA2, CARMN, CARS, CASP7, CCAR2, CCDC6, CCDC67, CCDC88C, CCNB3, CCND1, CCNH, CD101, CD44, CD63, CD74, CD99L2, CDC27, CDH11, CDH17, CDK5RAP2, CDX1, CEACAM5, CEP128, CEP192, CEP89, CHCHD7, CHD7, CIC, CIITA, CITED1, CITED2, CLCN6, CLDN1, CLIP1, CLIP2, CLN6, CLTC, CNNM3, COL12A1, COL17A1, COL1A, COL1A1, COL1A2, COL3A1, COL6A3, COMMD10, CPG, CPSF6, CREB1, CREB3L1, CREB3L2, CREB3L3, CREBBP, CREBZF, CREM, CRTC1, CRTC3, CSF1, CTB.35F21.1, CTNNA3, CTNNB1, CXCR4, CXorf67, DACH1, DAXX, DCTN1, DDIT3, DDX3X, DDX5, DIP2C, DKKL1, DNAH5, DNAJB6, DST, DTD1, DUS4L, DUX4, DUX4L2, E2F1, EEF1AKMT3, EGF, EGFR, EHBP1, EIF3E, ELF5, ELK4, ELN, EMILIN2, EML4, EMP1, EP300, EP400, EPC1, EPC2, EPS15, ERBB2, ERC1, ERG, ERLIN2, ESR1, ESRP1, EST14, ETV1, ETV2, ETV4, ETV5, ETV6, EWSR1, EZR, FAM131B, FAM227A, FER, FEV, FGF1, FGF2, FGFR1, FGFR2, FGFR3, FHIT, FIP1L1, FLI1, FLJ60017, FN1, FOSB, FOXO1, FOXO4, FOXO6, FOXP1, FOXR1, FUS, GCC2, GCNT3, GIT2, GLI1, GNAI1, GOLGA5, GOLGB1, GOPC, GPN1, GPS2, GREB1, GRIK2, GRM1, GSN, GTF2I, GTF3C2, GUCA2B, HAS2, HBA, HBA2, HBB, HENMT1, HERV-K, HERVK17, HEY1, HIP1, HIPK1, HLA-A, HMGA1, HMGA2, HMGN2P46, HNRNPA2B1, HOOK1, HOOK3, HOXD13, HS6ST2, HSPA8, HTN3, HTT, IG, IGF2, IGFBP5, IGH, IGK, IGL, IKBKG, INO80D, IRF2BP2, IRF4/DUSP22, ITD, JAK2, JAZF1, KANSL1, KAT6B, KCTD7, KDM2A, KDM2B, KDM4B, KHDRB52, KHSRP, KIAA1217, KIAA1549, KIAA1598, KIF5B, KIFC3, KIRREL, KLC1, KLF15, KLF17, KLHL29, KLHL7, KLK2, KMT2A, KRAS, KTN1, LACTB2, LAMTOR1, LIFR, LMAN2L, LMNA, LPP, LRIG3, LRRC31, LRRC34, LRRC59, LRRFIP1, LRRFIP2, LSM14A, LUC7L3, LYN, MAD1L1, MAGI3, MALAT1, MALT1, MAML2, MAML3, MAN2A1, MAP3K8, MBD1, MBTD1, MDK, MEAF6, MECOM, MED12, MEF2C, MEIS1, MELK, MET, MGA, MIPOL1, MIR143HG, MITF, MKL2, MKRN1, MLL, MLL4, MLPH, MPRIP, MSANTD3, MSN, MTOR, MXD1, MYB, MYBL1, MYC, MYH10, MYH9, MYO5A, NAB2, NACC2, NAV2, NCOA1, NCOA2, NCOA3, NCOA4, NCOR2, ND4, NDRG1, NF1, NFASC, NFATC1, NFATC2, NFIA, NFIB, NOL4L, NONO, NOS2, NOTCH1, NOTCH2, NOTCH3, NPC1, NPM1, NR4A3, NRG1, NSD3, NTRK1, NTRK2, NTRK3, NUDCD3, NUMA1, NUP160, NUP214, NUP98, NUTM1, NUTM2A, NUTM2B, NUTM2E, OFD1, OGDH, OMD, PAFAH1B2, PAN3, PAPSS1, PARP14, PATZ1, PAX3, PAX5, PAX7, PAX8, PBX1, PBX3, PDCD1LG2, PDE3B, PDE4DIP, PDE8A, PDGFB, PDGFD, PDGFRA, PDGFRB, PDHX, PDPN, PHF1, PIK3C2A, PITPNC1, PLA2G6, PLAG1, PLIN3, PML, POM121, POU1F1, POU3F1, POU5F1, PPAPDC1A, PPARG, PPFIBP1, PPL, PPP1R1B, PPP6R3, PRB3, PRCC, PRDM10, PRG4, PRKAR1A, PRKCA, PRKCB, PRKCD, PRKD1, PRKDC, PRKG1, PSD2, PSMA8, PTCH1, PTEN, PTMA, PTPRD, PTPRJ, PTPRK, PTPRZ1, PVT1, PWWP2A, QKI, RAB2A, RABGAP1L, RAD51, RAD51B, RAD52, RAF1, RANBP2, RARG, RBM10, RCC1, RELA, RET, RFWD2, RNF13, RNF130, RNF213, ROS1, RP11.57H14.3, RPLP1, RPS11, RRBP1, RREB1, RSPO2, RSPO3, RUNX1, S100A10, SCARB1, SCYL3, SDC4, SEC31A, SEC61G, SERINC1, SERPINE1, SET, SETBP1, SFMBT1, SFPQ, SHH, SLC11A2, SLC12A7, SLC16A7, SLC1A2, SLC26A11, SLC34A2, SLC3A2, SLC43A3, SLC45A2, SLC45A3, SLC5A11, SLC7A14, SMAD2, SMAD3, SMARCA4, SMARCA5, SNAPC3, SND1, SNX19, SOS1, SOX6, SP3, SPATA16, SPECC1L, SPTBN1, SQSTM1, SRF, SS18, SS18L1, SSX1, SSX2, SSX2B, SSX4, STARD3, STAT6, STK32B, STRN, SUZ12, SVIL, TACC1, TACC3, TAF15, TAX1BP1, TBL1XR1, TCEA1, TCF12, TCF4, TCF7L2, TEAD1, TENM4, TERT, TFCP2, TFE3, TFEB, TFG, TGFBR3, THBS1, THRAP3, TIMP3, TLN2, TMEM135, TMPRSS2, TNC, TNS3, TOM1L2, TOP2B, TP53, TP53BP1, TPM1, TPM3, TPM4, TPR, TPRG1, TPTEP1, TRA2B, TRIM11, TRIM24, TRIM27, TRIM33, TRIM4, TRIO, TRIT1, TRMT11, TSFM, TTC17, TTC28, TTYH1, UBE2L3, UBR5, ULK4, USP6, VCL, VGLL2, VGLL3, VGLL4, VIM, VMP1, VTI1A, WDR91, WHSC1L1, WIF1, WT1, WWTR1, YAP1, YWHAE, YY1, ZC3H7B, ZCCHC8, ZFP36, ZFPM2, ZKSCAN1, ZKSCAN5, ZMYM2, ZNF207, ZNF217, ZNF278, ZNF423, ZNF444, ZNF521, ZNF595, ZNF737, ZNF9

Unlisted gene 2
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Fusion transcript unlisted gene 2

PARAFFIN (8 items)

Number of paraffin blocks with tumour
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Number of paraffin blocks with tumour available in your Centre

TMA
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: if sample of paraffin block is included in a TMA (Tissue Micro Array)
Possible values : No, Yes

Storage centre
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Centre where TMA is stored
Possible values : ANGERS, ARTTIC, BERGONIE, BRUXELLES, CAEN, CCRC, CLERMONT-FERRAND, Cochin, CURIE, DIJON, ERASM, HENRI MONDOR, ICR, IGR, INT, IPSO, KLEUVEN, LAUSANNE, LBPA, LCC, LILLE, MARSEILLE CHU, MARSEILLE IPC, MAUNIHEI, MONTPELLIER, NANCY, NANTES, NICE, P-MAR, Paris Ouest, Rennes, SAINT-CLOUD, SANAV, SLS, STRASBOURG, TOULOUSE, UCBL, UNIPD, Warsaw Cancer Center, Bonn University

Web review
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : if the case has been reviewed using virtual slide
Possible values : No, Yes

Array-CGH
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: array-CGH done
Possible values : Not done, Done non interpretable, Done interpretable

Genomic index
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Value of genomic index
Possible values : GI1, GI2

ExomeSeq
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Not done, Done non interpretable, Done interpretable

MethylSeq
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Not done, Done non interpretable, Done interpretable

FROZEN_TISSUE (16 items)

Storage temperature
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Storage temperature of the frozen material according to the scroll menu
Possible values : -80°C, -140°C, Liquid nitrogen

Availability of tissue sample
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Available: frozen material has not been used and is available in the local Center In use: frozen material is currently in use in one or several studies Terminated: there is no frozen material left but nucleic acids (DNA and/or RNA, 0) may be still available
Possible values : Terminated, In use, Available

Karyotyping
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: karyotype done
Possible values : Not done, Done

Specific translocation
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: karyotype showes a translocation
Possible values : t(X;17)(p11;q25) (Alveolar soft part sarcoma), t(9;22)(q22;q12) (Extraskeletal myxoid chondrosarcoma), t(9;17)(q22;q11) (Extraskeletal myxoid chondrosarcoma), t(9;15)(q22;q21) (Extraskeletal myxoid chondrosarcoma), t(12;22)(q13;q12) (Clear cell sarcoma), t(11;22)(p13;q12) (Desmoplastic small round cell tumor), t(17;22)(q21;q13) (Dermatofibrosarcoma protuberans), t(11;22)(q24;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(21;22)(q22;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(7;22)(p22;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(17;22)(q12;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(2;22)(q33;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(1;16)(q21;q13) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(12;16)(q13;p11) (Liposarcoma, myxoid/round cell), t(12;22)(q13;q12) (Liposarcoma, myxoid/round cell), t(2;13)(q35;q14) (Alveolar rhabdomyosarcoma), t(1;13)(p36;q14) (Alveolar rhabdomyosarcoma), t(X;18)(p11;q11) (Synovial sarcoma)

Array-CGH
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: array-CGH done
Possible values : Not done, Done non interpretable, Done interpretable

RNA expression profile
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: expression profile done
Possible values : Not done, Done non interpretable, Done interpretable

Weight of frozen tissue
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Total weigh of frozen tumours fragments in mg

Number of tubes
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Number of tubes containing tumour fragments stored

Vamp ID
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

SNP analysis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: SNP analysis done
Possible values : Not done, Done non interpretable, Done interpretable

miRNA analysis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: miRNA analysis done
Possible values : Not done, Done non interpretable, Done interpretable

Genomic index
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Value of genomic index
Possible values : GI1, GI2

CINSARC
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Value of CINSARC
Possible values : C1, C2

ExomeSeq
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Not done, Done non interpretable, Done interpretable

Whole Genome Sequencing
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Not done, Done non interpretable, Done interpretable

MethylSeq
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Not done, Done non interpretable, Done interpretable

BLOOD_SAMPLE (7 items)

Treatment before sampling
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description : No : no treatment of the tumour event before sampling Chemotherapy: the tumour event has been received a chemotherapy before sampling Radiotherapy: radiotherapy on the tumour event before sampling ILP: an isolated limb perfusion procedure has been performed on the tumour event before sampling Other: other treatment has been performed on the tumour event before sampling
Possible values : No, Systemic treatment, Radiotherapy, ILP, Other

Sample reference
Type : Free value	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : Yes
Description : The sample reference in the center

Date of sampling
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date on which the sample was removed

Storage centre
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Centre where TMA is stored
Possible values : ANGERS, ARTTIC, BERGONIE, BRUXELLES, CAEN, CCRC, CLERMONT-FERRAND, Cochin, CURIE, DIJON, ERASM, HENRI MONDOR, ICR, IGR, INT, IPSO, KLEUVEN, LAUSANNE, LBPA, LCC, LILLE, MARSEILLE CHU, MARSEILLE IPC, MAUNIHEI, MONTPELLIER, NANCY, NANTES, NICE, P-MAR, Paris Ouest, Rennes, SAINT-CLOUD, SANAV, SLS, STRASBOURG, TOULOUSE, UCBL, UNIPD, Warsaw Cancer Center, Bonn University

Type of material
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Type of material stored
Possible values : Serum, Plasma, Lymphocytes, Total blood

Consent
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: consent obtained from the patient
Possible values : Yes, No, NA

Whole Genome Sequencing
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Not done, Done non interpretable, Done interpretable

CELL_LINE (11 items)

Number of passages
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Number of passages after put in culture of cells
Possible values : -30, +30

Dilution
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Dilution done at each passage
Possible values : 1/2, 1/4, 1/8, 1/10

Passage frequency
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Number of days between 2 passages

Molecular validation
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Method to check cells are tumorous by chromosome spreading, FISH or sequencing
Possible values : Yes, No, Not available

Array-CGH
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: array-CGH done
Possible values : Not done, Done non interpretable, Done interpretable

RNA expression profile
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: expression profile done
Possible values : Not done, Done non interpretable, Done interpretable

miRNA analysis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: miRNA analysis done
Possible values : Not done, Done non interpretable, Done interpretable

MultiFISH
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: multiFISH done
Possible values : not done, done interpretable, not interpretable

Genomic index
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Value of genomic index
Possible values : GI1, GI2

CINSARC
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Value of CINSARC
Possible values : C1, C2

Cell line reference
Type : Free value	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : Yes
Description : The cell line reference in the center

CHEMOTHERAPY_LINE (11 items)

Performance status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : 0 Fully active, able to carry out all pre-disease performance without restriction1 (Restricted) impairment in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work2 Ambulatory and capable of all selfcare but unable to carry out any work activities for more than 50% of waking hours3 Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours4 Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair
Possible values : 0, 1, 2, 3, 4, NA

Date of first cycle
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date start of cycle of chemotherapy

Drugs
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : 90Y-Ibritumomab tiuxetan, Abraxane, Abemaciclib, ADEPT, AINS, Aldesleukin, Aldoxorubicin, Alectinib, Alemtuzumab, AMG 706, Amsacrine, Atezolizumab, Avapritinib, Avelumab, Azacitidine, Bendamustine, Bevacizumab, Bezuclastinib/CGT9486, BI2536, Binimetinib, Bintrafusp Alfa , BKM120 - Buparlisib, Bleomycin, Bortezomib, Brostallicin, Busulfan, Cabazitaxel, Capecitabine, Carboplatin, Cabozantinib, Carmustine, Ceritinib, Cetuximab, Chlorambucil, Cisplatin, Cixutumumab, Cladribine, Clofarabine, Cobimetinib, Conatumumab, Crenigacestat, Crenolanib, Crisantaspase, Crizotinib, Cyclophosphamide, Cytarabine, Dabrafenib, Dacarbazine, Dactinomycin, Dalotuzumab, Dasatinib, Daunorubicin, DCC-2618, Deforolimus, Denosumab, Docetaxel, Dovitinib, Doxorubicin, Durvalumab, Emactuzumab, Encorafenib, Entrectinib, Epirubicin, Eribulin, Erlotinib, Etoposide, Everolimus, Evofosfamide, Farmorubicine, FDH, Figitumumab, Fludarabine, Fluorouracil, Fotemustin, FPA0008, Fulvestrant, Gefitinib, Gemcitabine, Gemtuzumab, Gimatecan, Gliadel implants, Halichondrin B, Hormonotherapy, Hydroxycarbamide, Idarubicin, IDRX-42, Ifosfamide, Imatinib, Interferon alpha, Interleukin-2, Iodine-131 tositumomab, Ipilimumab, Irinotecan, JX-594(Pexa-vec), Lapatinib, Larotrectinib, Lenalidomide, Lenvatinib, Leucovorin, Liposomal daunorubicin, Liposomal doxorubicin, Lomustine, Lornatinib, Masitinib, Melphalan, Mercaptopurine, Mesna, Methotrexate, Mitomycin, Mitotane, Mitoxantrone, Motesanib, NB003, NBTXR3, NGR-hTNF, Nilotinib, Nintedanib, Nivolumab, NVL-655, Olaparib, Olaratumab, Ombrabulin, Ontuxizumab (MORAb-004), Oxaliplatin, Paclitaxel, Palbociclib, Palifosfamide, Panitumumab, Panobinostat, Pazopanib, Pembrolizumab, Pemetrexed, Pentostatin, Pexidartinib, Placebo, Ponatinib, Prednisolone, Procarbazine, R1507 (Teprotumumab), Raltitrexed, Ramucirumab, Rasburicase, Regorafenib, Relatlimab, Ribociclib, Ridaforolimus, Ripretinib, Rituximab, RO5045337 / RG7112 (Nutlin), S9788, Satraplatin, Selpercatinib, Siremadlin (HDM201), Sirolimus, Sorafenib, Streptozocin, Sunitinib, Tamoxifen, Tasonermine, Tazemetostat, Tegafur-uracil, Temozolomide, Temsirolimus, Tenoposide, Thalidomide, Thiotepa, Tioguanine, Topotecan, Trabectedin, Trametinib, Trastuzumab, Tremelimumab, Treosulfan, Vinblastine, Vemurafenib, Vincristine, Vindesine, Vinorelbine, Vismodegib, Vistusertib, Warfarin, Other

Best RECIST Response chemo
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Best response observed during chemotherapy: complete response; partial response; stable disease or progressive disease
Possible values : Complete response, Partial response, Stable disease, Progressive disease, Not evaluable

Date progression chemo
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of tumour progression under chemotharapy

Clinical trial
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour
Possible values : No, Yes

Rank of Chemotherapy line
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Rank of Chemotherapy line

Clinical trial name
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Clinical trial name according to the scroll menu
Possible values : Clinical trial name to complete, 105SAR301 TAPPAS, 20140114, AB04030, AB07001, AB1010, AB11002, AcSé Crizotinib, ACSE Pembrolizumab, Acsé-eSMART-CSET, ADP-0044-002 - SPEARHEAD 1, ALDOXORUBICIN, ALTGIST, AGADIR, AMG706, AMGEN 20060324, ANGIO-NEXT, ANGIOTAX, ANGIOTAX-PLUS, ANNOUNCE 1, ARO-012 CRENOGIST, ASCEND10, ATEZOGIST, BAY734506, BET115521, BFR14, BKM120, BLU-285-1101, BLU-285-1303 , BO20924, BP27772, BP29428, BROSTALLICINE, CA017-003, CA209-848, CABOGIST, CABONE, CAIRE, CAMN107, CGM097, CHDM201X2103C, CHONDROG, CHONRAD, CISTEM, COMBINAIR 3, CONGRATS, CRAD001C2206, CRAD001X2109, CREATE, CSTI571X2103, CYCLIGIST, DCC2618-03-002 : INTRIGUE, DCC2618-23-001 : INTRIGUE , DESMOPAZ, DOVIGIST, E7389-G000-213, E7438-G000-101, EFC 10145, EISAI E7389, EORTC-1202, EORTC-1403-REECUR, EORTC-1447-STBSG, EORTC-1506-STBSG-ANITA, EORTC-62005, EORTC-62012, EORTC-62022-IRESSA , EORTC-62024, EORTC-62043, EORTC-62052, EORTC-62061-STBSG, EORTC 62113-55115 HGUS, EORTC-62953, EORTC-62972, EORTC-90061-BI2536, EORTC STI571, EREMISS, ESPACE, ESTIM-LBH, ET-743, ETC-002-07, EURO-EWING, EURO-EWING 2012, EUROSARC, EZH-102 (EPIZYME), EZH-202, EZH-501, Far-RMS, FDH-609, FIVE PRIME, GCS O12, GEIS-32, GERICO 14, GIGIST-LB, GIMATECAN, GO29664, GP28153, H6Q-MC-JCAY, I3G-MC-JGCB, I5B-MC-JGDJ : ANNOUNCE, I5B-MC-JGDL : ANNOUNCE 2, I5B-MC-JGDM, I6F-MC-JJCD, IDRX-42-001, IMCLONE, IMADGIST, INTRIGUE DCC 2618 03002, INVICTUS, ISI-JX, IROFULVEN, KCP-330-020 SEAL, KIDES-203, LEE011, LENVAGIST, LMS02, LMS03, LMS04, LOXO-TRAK, MDR-S9788, MEGAMOST, MEKi, MEN 10755, METRO-PD1, METROMAJX, METZOLIMOS, MK 7339, MK 7902-013, MK 8669-DALORI, ML43313-COTESARC, MMT 95, MO29518 basket, MOLMED, MORAb-004, MOST, MOST Plus, MULTISARC C16-40, NAVE-CYCLO, NB003-01, NBTXR3-301, NEOSARCOMICS, NP27872, NP28021, NVL-655-01, OP690, OS 2006, OSII-TTP, PAL-ANGI3, PALETTE, PALSAR, PALSAR II, PAZOGIST, PEAK, PEMBROSARC, PICASSO, PICASSO 3, PIPER, PLX108-10, PO4720, PRESOV, PVNS, RADIOSARP, RAR-IMMUNE, REGISTRI, REGO INTER EWING-1, REGO-SARC, REGOBONE, REGOMAIN, REGOMUNE, REGOSTA, RMS 2005, RT-IMMUNE, RT-SUTENT, SAKK 56/07, SAR-1001, SAR04/0205, SARC011 R1507, SARC021-THRESHOLD, SARCOME 13, SCH717454, SEAL-KCP-330-020 , SHIVA, STARTRK2, STARTRK GO40782, STI 571, STING GSK 208850, SU011248, SUCCEED, SYNFRIZZ, TAIL, TAPISTRY BO41932 , TAPPAS, TARMIC, TAXOGEM, T-DIS, TH-CR-406, TH302, TRAMUNE, TRAST, TRUST, TSAR, VEBASKET, VEG105430 , VINFLUNINE IN104, VIT-0910, XGEVA AMGEN

Progression chemo
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: the patient had progressive disease at the date of last-follow up; no: no progressive disease observed at the date of last follow-up
Possible values : Yes, No, Not available

DateEndCycle
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

IndicSTTTLine
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Neo-adjuvant, Adjuvant, Palliative, Maintenance

IMMUNOHC (7 items)

Mib1%
Type : Free value	Content : PERCENTAGE	Mandatory : No	Multiple values : No	Unique : No
Description :

Other markers
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

Positive markers
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fos B , Fox2B, FoxL2, Fli1, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K36M (H3F3B), H3K27, HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Ki67, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NKX2.2, NKX3.1, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, SS18-SSX, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1

Positive diffuse markers
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, EBV (LMP), E-Cadherin, EGFr, EMA, HHF35, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K27, H3K36M (H3F3B), HBK27, Helicobacter pylori, HER2, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, SS18-SSX, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1

Positive focal markers
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K36M (H3F3B), H3K27, HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Pancytokeratin AE1/AE3, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, SS18-SSX, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1

Negative markers
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K27, H3K36M (H3F3B), HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Ki67, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NRAS (Q61R), NSE, NR3C4, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, STAT 6, SS18-SSX, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1

Not interpretable markers
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K27, H3K36M (H3F3B), HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Ki67, KL1, MDM4, MDM2, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, STAT 6, SS18-SSX, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1

MOLECULARCG (76 items)

P53 mutation status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, Non amplifiable DNA

P53 nucleotidic formula 1
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

P53 proteic formula 1
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

P53 nucleotidic formula 2
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

P53 polymorphism
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Yes, No

Translocation analysis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Yes, No

Amplification analysis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Yes, No

RT-PCR
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

FISH
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : FISH performed
Possible values : No, Yes

TypeTechINI1
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

INI1 status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, Non amplifiable DNA

TypeTechCTNNB1
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

Exon 3 status (CTNNB1)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : 41A mutation, 45F mutation, 45P mutation, Other mutation, No mutation, Non amplifiable DNA

TypeTechAPC
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

APC status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, Non amplifiable DNA

TypeTechMDM2
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : FISH, Q-PCR, Array-CGH, Other

Result MDM2
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Negative, Positive, Non interpretable

TypeTechCDK4
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : FISH, Q-PCR, Array-CGH, Other

Result CDK4
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Negative, Positive, Non interpretable

TypeTechTP53
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Sequencing, Functional assay, Both, Other

P53 proteic formula 2
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

P53 functional status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : WT, Mut

Negative transcript (RT-PCR)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : Transcript (PNET), EWSR1-FLI1 (PNET), EWSR1-ERG (PNET), EWSR1-ETV1 (PNET), EWSR1-FEV (PNET), EWSR1-ETV4 (PNET), FUS-ERG (PNET), CIC-DUX4 (Ewing -like), BCOR-CCNB3 (Ewing-like), Transcript (synovial sarcoma), SSI8-SSX1 (synovial sarcoma), SSI8-SSX2 (synovial sarcoma), SSI8-SSX4 (synovial sarcoma), SSI8L1-SSX1 (synovial sarcoma), Transcript (alveolar rhabdomyosarcoma), PAX3-FOXOA1 (alveolar rhabdomyosarcoma), PAX7-FOXOA1 (alveolar rhabdomyosarcoma), PAX3-MLLT7 (alveolar rhabdomyosarcoma), PAX3-NCOA1 (alveolar rhabdomyosarcoma), EWSR1-WT1 (desmoplastic round cell tumour), Transcript (myxoid liposarcoma), FUS-DDIT3 (myxoid liposarcoma), EWSR1-DDIT3 (myxoid liposarcoma), EWSR1-ATF1 (clear cell sarcoma), Transcript (extraskeletal myxoid chondrosarcoma), EWSR1-NR4A3 (extraskeletal myxoid chondrosarcoma), TAF1168-NR4A3 (extraskeletal myxoid chondrosarcoma), TCF12-NR4A3 (extraskeletal myxoid chondrosarcoma), TFG-NR4A3 (extraskeletal myxoid chondrosarcoma), COL1A1-PDGFB (dermatofibrosarcoma protuberans), Transcript (low grade fibromyxoid sarcoma), FUS-CREB3L2 (low grade fibromyxoid sarcoma), FUS-CREB3L1 (low grade fibromyxoid sarcoma), ASPL-TFE3 (alveolar soft part sarcoma), ASPSCR1-TFE3 (alveolar soft part sarcoma), ETV6-NTRK3 (congenital fibrosarcoma), Transcript (endometrial stromal sarcoma), JAZF1/SUZ12 (endometrial stromal sarcoma), YWHAE-FAM22 (endometrial stromal sarcoma), YWHAE-NUTM22A/B (endometrial stromal sarcoma), PAX-MAML3 (sinonasal sarcoma) , PAX3-NCOA1 (sinonasal sarcoma), MYH9-USP6 (fasciitis), EWSR1-ETAF1, EWSR1-PATZ1, CLTC-ALK, hSNF5/INI1 (malignant rhabdoid tumors), EWSR1-CREB3L2, NAB2-STAT6, SRF-NCOA1, FUS/FEV, EWS/NFATc2, EWSR1-CREB1, WWTR1-CAMTA1

Positive transcript (RT-PCR)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : Transcript (PNET), EWSR1-FLI1 (PNET), EWSR1-ERG (PNET), EWSR1-ETV1 (PNET), EWSR1-FEV (PNET), EWSR1-ETV4 (PNET), FUS-ERG (PNET), CIC-DUX4 (Ewing -like), BCOR-CCNB3 (Ewing-like), Transcript (synovial sarcoma), SSI8-SSX1 (synovial sarcoma), SSI8-SSX2 (synovial sarcoma), SSI8-SSX4 (synovial sarcoma), SSI8L1-SSX1 (synovial sarcoma), Transcript (alveolar rhabdomyosarcoma), PAX3-FOXOA1 (alveolar rhabdomyosarcoma), PAX7-FOXOA1 (alveolar rhabdomyosarcoma), PAX3-MLLT7 (alveolar rhabdomyosarcoma), PAX3-NCOA1 (alveolar rhabdomyosarcoma), EWSR1-WT1 (desmoplastic round cell tumour), Transcript (myxoid liposarcoma), FUS-DDIT3 (myxoid liposarcoma), EWSR1-DDIT3 (myxoid liposarcoma), EWSR1-ATF1 (clear cell sarcoma), Transcript (extraskeletal myxoid chondrosarcoma), EWSR1-NR4A3 (extraskeletal myxoid chondrosarcoma), TAF1168-NR4A3 (extraskeletal myxoid chondrosarcoma), TCF12-NR4A3 (extraskeletal myxoid chondrosarcoma), TFG-NR4A3 (extraskeletal myxoid chondrosarcoma), COL1A1-PDGFB (dermatofibrosarcoma protuberans), Transcript (low grade fibromyxoid sarcoma), FUS-CREB3L2 (low grade fibromyxoid sarcoma), FUS-CREB3L1 (low grade fibromyxoid sarcoma), ASPL-TFE3 (alveolar soft part sarcoma), ASPSCR1-TFE3 (alveolar soft part sarcoma), ETV6-NTRK3 (congenital fibrosarcoma), Transcript (endometrial stromal sarcoma), JAZF1/SUZ12 (endometrial stromal sarcoma), YWHAE-FAM22 (endometrial stromal sarcoma), YWHAE-NUTM22A/B (endometrial stromal sarcoma), PAX-MAML3 (sinonasal sarcoma) , PAX3-NCOA1 (sinonasal sarcoma), MYH9-USP6 (fasciitis), EWSR1-PATZ1, EWSR1-ETAF1, CLTC-ALK, hSNF5/INI1 (malignant rhabdoid tumors), EWSR1-CREB3L2, NAB2-STAT6, SRF-NCOA1, FUS/FEV, EWS/NFATc2, EWSR1-CREB1, WWTR1-CAMTA1

Non interpretable transcript (RT-PCR)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : Transcript (PNET), EWSR1-FLI1 (PNET), EWSR1-ERG (PNET), EWSR1-ETV1 (PNET), EWSR1-FEV (PNET), EWSR1-ETV4 (PNET), FUS-ERG (PNET), CIC-DUX4 (Ewing -like), BCOR-CCNB3 (Ewing-like), Transcript (synovial sarcoma), SSI8-SSX1 (synovial sarcoma), SSI8-SSX2 (synovial sarcoma), SSI8-SSX4 (synovial sarcoma), SSI8L1-SSX1 (synovial sarcoma), Transcript (alveolar rhabdomyosarcoma), PAX3-FOXOA1 (alveolar rhabdomyosarcoma), PAX7-FOXOA1 (alveolar rhabdomyosarcoma), PAX3-MLLT7 (alveolar rhabdomyosarcoma), PAX3-NCOA1 (alveolar rhabdomyosarcoma), EWSR1-WT1 (desmoplastic round cell tumour), Transcript (myxoid liposarcoma), FUS-DDIT3 (myxoid liposarcoma), EWSR1-DDIT3 (myxoid liposarcoma), EWSR1-ATF1 (clear cell sarcoma), Transcript (extraskeletal myxoid chondrosarcoma), EWSR1-NR4A3 (extraskeletal myxoid chondrosarcoma), TAF1168-NR4A3 (extraskeletal myxoid chondrosarcoma), TCF12-NR4A3 (extraskeletal myxoid chondrosarcoma), TFG-NR4A3 (extraskeletal myxoid chondrosarcoma), COL1A1-PDGFB (dermatofibrosarcoma protuberans), Transcript (low grade fibromyxoid sarcoma), FUS-CREB3L2 (low grade fibromyxoid sarcoma), FUS-CREB3L1 (low grade fibromyxoid sarcoma), ASPL-TFE3 (alveolar soft part sarcoma), ASPSCR1-TFE3 (alveolar soft part sarcoma), ETV6-NTRK3 (congenital fibrosarcoma), Transcript (endometrial stromal sarcoma), JAZF1/SUZ12 (endometrial stromal sarcoma), YWHAE-FAM22 (endometrial stromal sarcoma), YWHAE-NUTM22A/B (endometrial stromal sarcoma), PAX-MAML3 (sinonasal sarcoma) , PAX3-NCOA1 (sinonasal sarcoma), MYH9-USP6 (fasciitis), EWSR1-PATZ1, EWSR1-ETAF1, CLTC-ALK, hSNF5/INI1 (malignant rhabdoid tumors), EWSR1-CREB3L2, NAB2-STAT6, SRF-NCOA1, FUS/FEV, EWS/NFATc2, EWSR1-CREB1, WWTR1-CAMTA1

Negative (FISH)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : EWSR1 (BA), SSI8 (BA), FOXOA1 (BA), FUS (BA), DDIT3 (BA), ETV6 (BA), PDGFB (BA), COL1A1- PDGFB (fusion), CIC (BA), JAZF1 (BA), USP6 (BA), PHF1 (BA), TFE3 (BA), YWHAE (BA), CAMTA1-WWTR1 (Fusion), ALK (BA), PAX3 (BA), NCOA2 (BA), NR4A3 (BA), H3.3G34W (H3F3A), H3K36M (H3F3B), IDH1/IDH2, GNAS, BCOR, CCNB3, EWSR1-ERG, EWSR1-FLI1, WWTR1 (BA), CKN2A (P16), CAMTA1 (BA), SRF, WT1, NTRK3, VGLL3, CSF1, COL1A1, MGEA5, PTEN, SMARCB1 (INI1), ROS1, RET, CIC-DUX4, PLAG1, NUTM1, FOSB, HMGA2, ERG, BRAF, VGLL2, MAP3K3, WWTR1-CAMTA1 (Fusion), NAFTC3, PRDM10, GRM1, TFCP2, NTRK1, USP2, YAP1, TRIM11, RB1, FN1, APOD, FGFR1, PRKCD

Positive (FISH)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : EWSR1 (BA), SSI8 (BA), FOXOA1 (BA), FUS (BA), DDIT3 (BA), ETV6 (BA), PDGFB (BA), COL1A1- PDGFB (fusion), CIC (BA), USP6 (BA), PHF1 (BA), TFE3 (BA), YWHAE (BA), JAZF1 (BA), CAMTA1-WWTR1 (Fusion), ALK (BA), PAX3 (BA), NCOA2 (BA), NR4A3 (BA), H3.3G34W (H3F3A), H3K36M (H3F3B), IDH1/IDH2, GNAS, BCOR, CCNB3, EWSR1-FLI1, EWSR1-ERG, WWTR1 (BA), CKN2A (P16), CAMTA1 (BA), SRF, WT1, NTRK3, VGLL3, CSF1, COL1A1, MGEA5, PTEN, SMARCB1 (INI1), ROS1, RET, CIC-DUX4, PLAG1, NUTM1, FOSB, ERG, BRAF, VGLL2, MAP3K3, WWTR1-CAMTA1 (Fusion), NAFTC3, PRDM10, GRM1, TFCP2, NTRK1, USP2, YAP1, TRIM11, HMGA2, RB1, FN1, APOD, FGFR1, PRKCD

Non interpretable (FISH)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : CIC (BA), COL1A1- PDGFB (fusion), DDIT3 (BA), ETV6 (BA), EWSR1 (BA), FOXOA1 (BA), FUS (BA), PDGFB (BA), PHF1 (BA), JAZF1 (BA), SSI8 (BA), TFE3 (BA), USP6 (BA), YWHAE (BA), CAMTA1-WWTR1 (Fusion), ALK (BA), PAX3 (BA), NCOA2 (BA), NR4A3 (BA), H3.3G34W (H3F3A), H3K36M (H3F3B), IDH1/IDH2, GNAS, BCOR, CCNB3, EWSR1-FLI1, EWSR1-ERG, WWTR1 (BA), CAMTA1 (BA), CKN2A (P16), SRF, WT1, NTRK3, VGLL3, CSF1, COL1A1, MGEA5, PTEN, SMARCB1 (INI1), ROS1, RET, CIC-DUX4, PLAG1, NUTM1, FOSB, ERG, BRAF, VGLL2, MAP3K3, WWTR1-CAMTA1 (Fusion), NAFTC3, PRDM10, GRM1, TFCP2, NTRK1, USP2, YAP1, TRIM11, RB1, HMGA2, FN1, APOD, FGFR1, PRKCD

GenesMut
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : APC, BRAF, CTNNB1, GNAS, H3F3A, H3F3B, INI1, KIT, MYOD1, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD, SMARCA4, SMARCB1, TP53, Other

GenesAmp
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : CDK4, CMYC, MDM2, Other

BRAF status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : V600E, Other, No mutation, Non amplifiable DNA

TypeTechBRAF
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

GNAS status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechGNAS
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

H3F3A status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechH3F3A
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

H3F3B status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechH3F3B
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

KIT status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : Exon9, Exon11, Exon13, Exon17, Other exon, No mutation, No amplifiable DNA

TypeTechKIT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

MYOD1 status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechMYOD1
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

NF1 status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechNF1
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

PDGFRA status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : Exon12, Exon14, Exon18, Other exon, No mutation, No amplifiable DNA

TypeTechPDGFRA
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

SDHA status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechSDHA
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

SDHB status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechSDHB
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

SDHC status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechSDHC
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

SDHD status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechSDHD
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

SMARCA4 status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechSMARCA4
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

SMARCB1 status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechSMARCB1
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

KIT Nucleotidic formula exon 9
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

KIT Proteic formula exon 9
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

ResultCMYC
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Negative, Positive, Non interpretable

TypeTechCMYC
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : FISH, Q-PCR, Array-CGH, Other

OtherGenesAmp
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

OtherGenesMut
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

PDGFRA Nucleotidic formula exon 12
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

PDGFRA Proteic formula exon 12
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

KIT Proteic formula exon 11
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

KIT Nucleotidic formula exon 11
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

KIT Proteic formula exon 13
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

KIT Nucleotidic formula exon 13
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

KIT Proteic formula exon 17
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

KIT Nucleotidic formula exon 17
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

PDGFRA Proteic formula exon 14
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

PDGFRA Nucleotidic formula exon 14
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

PDGFRA Proteic formula exon 18
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

PDGFRA Nucleotidic formula exon 18
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

RCP (12 items)

Date RCP
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date de la RCP

Centre of RCP
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Centre de RCP
Possible values : - CIRTAL National RCP - Adult Regional RCP - RCP Besançon - RCP Bordeaux - RCP Caen - RCP Clermont-Ferrand - RCP Dijon - RCP Dom Tom La Réunion - RCP Lille - RCP Limoges - RCP Lyon - RCP Marseille IPC - RCP Marseille Timone - RCP Montpellier - RCP Nancy - RCP Nantes/Angers - RCP Nice - RCP Paris APHP multisites GIST - RCP Paris Cochin - RCP Paris Curie - RCP Paris Pitié Salpetrière - RCP Paris Saint Louis - RCP Paris Tenon - RCP Poitiers - RCP Reims Debré GIST - RCP Reims Godinot - RCP Rennes/Brest - RCP Rouen - RCP Strasbourg - RCP Toulouse - RCP Tours - RCP Villejuif - Adult Inter Regional RCP - RCP IR Lille Caen Rouen Amiens - RCP IR Bordeaux Limoges Montpellier Toulouse - RCP IR Nantes Angers Rennes - RCP IR Grand Est (Nancy, Besancon, Dijon, Reims, Strasbourg) - Pediatric Inter Regional RCP - RCP pediatric Est (Besancon,Dijon,Nancy,Reims,Strasbourg) - RCP pediatric Grand Ouest (Angers,Brest,Caen,Nantes,Poitiers,Rennes,Tours) - RCP pediatric Ile de France/La Reunion - RCP pediatric Nord (Amiens,Lille,Rouen) - RCP pediatric Rhone-Alpes/Auvergne (Clermont-Ferrand,Grenoble, Lyon, Saint-Etienne) - RCP pediatric Sud Est (Marseille,Montpellier,Nice) - RCP pediatric Sud Ouest (Bordeaux,Limoges,Toulouse) - RCP regional pediatric La Reunion

Clinical situation
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Situation de la prise en charge du patient lors de la RCP Si un patient a progressé il sera toujours en After progresssion pour toutes les RCP suivantes
Possible values : Before biopsy, Before neo-adjuvant treatment, Before surgery, Complementary treatment, After treatment, After progression

CT enrollment Proposal
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Essais clinique proposé par la RCP
Possible values : Yes, No

File number
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Numéro de dossier du patient dans votre établissement

Comment
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

Decision 1
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : - Indication for biopsy - Indication for staging - Indication for histological review - Indication for surgery - Indication for initial tumour surgery - Indication for metastasis surgery - Chemoembolisation - Radiofrequency - Cryotherapy - Indication for re-excision - Indication for ILP - No indication for surgery - Indication for radiotherapy - Indication for neoadjuvant radiotherapy - Indication for adjuvant radiotherapy - Indication for exclusive or palliative radiotherapy - No indication for radiotherapy - Indication for chemotherapy - Indication for neoadjuvant chemotherapy - Indication for adjuvant chemotherapy - Indication for metastatic chemotherapy - Targeted therapies - Continuation of chemotherapy protocol - Modification of chemotherapy dose - Modification of chemotherapy protocol - No indication for chemotherapy - Supportive or palliative care - Indication for hormone therapy - NSAI - Others - No indication for additional treatment - Request for supplementary examinations - Indication for surveillance program - Advisory opinion from another MCB - Advisory opinion from other specialists - Medical file to present (again) to a MCB

Decision 2
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : - Indication for biopsy - Indication for staging - Indication for histological review - Indication for surgery - Indication for initial tumour surgery - Indication for metastasis surgery - Chemoembolization - Radiofrequency - Cryotherapy - Indication for re-excision - Indication for ILP - No indication for surgery - Indication for radiotherapy - Indication for neoadjuvant radiotherapy - Indication for adjuvant radiotherapy - Indication for exclusive or palliative radiotherapy - No indication for radiotherapy - Indication for chemotherapy - Indication for neoadjuvant chemotherapy - Indication for adjuvant chemotherapy - Indication for metastatic chemotherapy - Targeted therapies - Continuation of chemotherapy protocol - Modification of chemotherapy dose - Modification of chemotherapy protocol - No indication for chemotherapy - Supportive or palliative care - Indication for hormone therapy - NSAI - Others - No indication for additional treatment - Request for supplementary examinations - Indication for surveillance program - Advisory opinion from another MCB - Advisory opinion from other specialists - Medical file to present (again) to a MCB

Decision 3
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : - Indication for biopsy - Indication for staging - Indication for histological review - Indication for surgery - Indication for initial tumour surgery - Indication for metastasis surgery - Chemoembolisation - Radiofrequency - Cryotherapy - Indication for re-excision - Indication for ILP - No indication for surgery - Indication for radiotherapy - Indication for neoadjuvant radiotherapy - Indication for adjuvant radiotherapy - Indication for exclusive or palliative radiotherapy - No indication for radiotherapy - Indication for chemotherapy - Indication for neoadjuvant chemotherapy - Indication for adjuvant chemotherapy - Indication for metastatic chemotherapy - Targeted therapies - Continuation of chemotherapy protocol - Modification of chemotherapy dose - Modification of chemotherapy protocol - No indication of chemotherapy - Supportive or palliative care - Indication for hormone therapy - NSAI - Others - No indication for additional treatment - Request for supplementary examinations - Indication for surveillance program - Advisory opinion from another MCB - Advisory opinion from other specialists - Medical file to present (again) to a MCB

CtEnrollmentComment
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : CT enrollment comment

Requesting center
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Établissement ou personne (médecin généraliste) adressant le patient en RCP
Possible values : Attending physician, Comprehensive Cancer Center, Universitary Hospital, General Hospital, PSPH, Private institution

Histotype
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Histotype of the primary tumour to be chosen in the scroll menu (2013 WHO classification, 0)
Possible values : - Benign lesion - Benign adipocytic tumours - Angiolipoma - Angiomyolipoma - Chondroid lipoma - Hibernoma - Lipoblastoma/lipoblastomatosis - Lipoma - Lipomatosis - Lipomatosis of nerve - Atypical spindle cell/pleomorphic lipomatous tumour - Myelolipoma - Myolipoma - Spindle cell / pleomorphic lipoma - Benign chondrogenic tumours - Chondroblastoma NOS - Chondroma - Chondromyxoid fibroma - Enchondroma - Osteochondroma - Osteochondromyxoma - Periosteal chondroma - Pulmonary chondroma - Pulmonary hamartoma - Subungueal exostosis - Synovial chondromatosis - Benign fibroblastic/myofibroblastic tumours - Adenofibroma - Angiofibroma - Angiomyofibroblastoma - Calcifying aponeurotic fibroma - Calcifying fibrous tumour - Cellular angiofibroma - Desmoplastic fibroblastoma - Elastofibroma - Fasciitis - Fibroblastic tumour with SMAD3 fusion - Fibrochondromyxoid tumour with THBS1 fusion - Fibro-osseous pseudotumour of digits - Fibroma of tendon sheath - Fibromatosis colli - Fibrous hamartoma of infancy - Gardner fibroma - Inclusion body fibromatosis - Intra-nodal palisaded myofibroblastoma - Ischaemic fasciitis - Juvenile hyaline fibromatosis - Myofibroblastoma - Myositis ossificans - Nasopharyngeal angiofibroma - Nodular fasciitis - Nuchal-type fibroma - Organ-associated pseudosarcomatous myofibroblastic proliferations - Other fibromas - Proliferative fasciitis - Proliferative myositis - Benign fibro-histiocytic tumours - Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws) - Deep benign fibrous histiocytoma - Epithelioid fibrous histiocytoma - Erdheim-Chester disease - Fibrous histiocytoma - Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma) - Langerhans cell histiocytosis - Non Ossifying fibroma - Rosai-Dorfman disease - Tenosynovial giant cell tumour NOS - Tenosynovial giant cell tumour, diffuse type - Tenosynovial giant cell tumour, localized type - Benign nerve sheath tumours - Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP - Benign Triton tumour - Dermal nerve sheath myxoma - Ectopic meningioma - Granular cell tumour - Hybrid nerve sheath tumours - Nasal glial heterotopia - Neurofibroma - Neurothekeoma - Perineurioma - Plexiform neurofibroma - Schwannoma - Solitary circumscribed neuroma - Benign notochordal tumour - Benign osteogenic tumours - Osteoid osteoma - Osteoma - Benign pericytic tumours - Angioleiomyoma - Glomus tumour - Myofibroma / myofibromatosis - Myopericytoma - Benign skeletal muscle tumours - Rhabdomyoma - Rhabdomyoma - adult type - Rhabdomyoma - fetal type - Rhabdomyoma - genital type - Benign smooth muscle tumours - Atypical polypoid adenomyoma - Adenomyoma - Bizarre nuclei leiomyoma - Cellular leiomyoma - Diffuse leiomyomatosis - Dissecans leiomyoma - Epithelioid leiomyoma - Intraveinous leiomyomatosis - Leiomyoma - Leiomyomatosis peritonealis disseminata - Mitotically-active leiomyoma - Myxoid leiomyoma - Benign tumours of uncertain differentiation - Acral fibromyxoma - Brown tumour - Deep (aggressive) angiomyxoma - Ectopic hamartomatous thymoma - Fibrous dysplasia - Inflammatory fibroid polyp - Intramuscular myxoma - Myxoma NOS - Osteofibrous dysplasia - Pleomorphic hyalinizing angiectatic tumour - Pleuropulmonary blastoma - Simple bone cyst - Superficial angiomyxoma - Benign vascular tumours - Angiolymphoid hyperplasia - Angiomatosis - Atypical vascular lesion - Diffuse pulmonary lymphangiomatosis - Epithelioid hemangioma - Gorham disease - Hemangioma - Intra-muscular hemangioma - Lymphangioma NOS - Lymphangiomatosis - Pyogenic granuloma - Osseous pseudo-tumours - Bizarre parosteal osteochondromatous proliferation - Callus - Florid ossificans periostitis - Post-traumatic fibro-osseous lesion - Tophaceous pseudogout - Other benign lesion - GIST - gastrointestinal stromal tumour (GIST), low, very low risk - gastrointestinal stromal tumour (GIST), intermediate risk - gastrointestinal stromal tumour (GIST), high risk - Non-mesenchymal malignant tumour - Carcinoma - Germinal tumor - Lymphoma - Melanoma - Myeloma - Other non-mesenchymal malignant tumours - Plasmocytoma - Other diagnoses - Diagnosis unspecified - Undifferentiated malignant tumour - Sarcoma - Chondrosarcoma - Central chondrosarcoma - Chondrosarcoma, grade 1 - Chondrosarcoma, grade 2 - Chondrosarcoma, grade 3 - Chondrosarcoma NOS - Clear cell chondrosarcoma - Dedifferentiated chondrosarcoma - Mesenchymal chondrosarcoma - Periosteal chondrosarcoma - Peripheral chondrosarcoma - Leiomyosarcoma - Leiomyosarcoma - differentiated - Leiomyosarcoma - epithelioid - Leiomyosarcoma - myxoid - Leiomyosarcoma - poorly-differentiated - Liposarcoma - Liposarcoma - dedifferentiated - Liposarcoma - mixed type - Liposarcoma - myxoid - Liposarcoma - NOS - Liposarcoma - pleomorphic - Liposarcoma - round cell - Liposarcoma - well differentiated - Myxoid pleomorphic liposarcoma - Malignant fibrohistiocytic tumours of bone - Malignant giant cell tumour of bone - Malignant peripheral nerve sheath tumour - Ectomesenchymoma - Malignant perineurioma - Malignant Triton tumour - MPNST - epithelioid type - MPNST - usual type - Miscellaneous sarcomas - Alveolar soft part sarcoma - Angiosarcoma - BCOR sarcoma - CIC-DUX sarcoma - CIC-rearranged sarcoma - Clear cell sarcoma - Desmoplastic round cell tumour - Epithelioid hemangioendothelioma NOS - Epithelioid hemangioendothelioma with TFE3 fusion - Epithelioid hemangioendothelioma with WWTR1 fusion - Epithelioid sarcoma - Ewing sarcoma - Extraskeletal myxoid chondrosarcoma - Fibrosarcoma NOS - High risk solitary fibrous tumour - Intimal sarcoma - Low grade fibromyxoid sarcoma - Low grade sinonasal sarcoma - Malignant glomus tumour - Malignant granular cell tumour - Malignant mesenchymoma - Malignant mixed tumor - Malignant myoepithelial tumour - Malignant ossifying fibromyxoid tumour - Malignant PECOMA - Malignant rhabdoid tumour - Malignant tenosynovial giant cell tumour - Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion - Sclerosing epithelioid fibrosarcoma - SMARCA4-deficient undifferentiated thoracic tumour - Myxofibrosarcoma - Osteosarcoma - Conventional osteosarcoma - Dedifferentiated low-grade central osteosarcoma - Dedifferentiated parosteal osteosarcoma - Extraskeletal osteosarcoma - High-grade surface osteosarcoma - Low-grade central osteosarcoma - Osteoblastoma-like osteosarcoma - Osteosarcoma NOS - Parosteal osteosarcoma - Periosteal osteosarcoma - Small cell osteosarcoma - Secondary osteosarcoma - Telangiectasic osteosarcoma - Other sarcomas - Adamantinoma - Adenosarcoma - Chondroid chordoma - Chordoma NOS - Dedifferentiated adamantimoma - Dedifferentiated chordoma - Endometrial stromal sarcoma - Endometrial stromal sarcoma - high-grade - Endometrial stromal sarcoma - low-grade - Phyllodes sarcoma - Poorly differenciated chordoma - Undifferentiated uterine sarcoma - Rhabdomyosarcoma - Adult spindle cell rhabdomyosarcoma - Alveolar rhabdomyosarcoma - Embryonal rhabdomyosarcoma - botryoid type - Embryonal rhabdomyosarcoma - NOS - Embryonal rhabdomyosarcoma - spindle cell type - Embryonal rhabdomyosarcoma - usual type - Pleomorphic rhabdomyosarcoma - Rhabdomyosarcoma - NOS - Rhabdomyosarcoma with MYOD1 mutation - Rhabdomyosarcoma with TFCP2 fusion - Rhabdomyosarcoma with VGLL2/NCOA2 fusion - Sclerosing rhabdomyosarcoma - Spindle cell rhabdomyosarcoma - Suspicion of sarcoma - Synovial sarcoma - Synovial sarcoma - biphasic - Synovial sarcoma - monophasic - Synovial sarcoma - NOS - Synovial sarcoma - poorly differentiated - Undifferentiated sarcoma - Undifferentiated epithelioid sarcoma - Undifferentiated pleomorphic sarcoma - Undifferentiated round cell sarcoma - Undifferentiated sarcoma - NOS - Undifferentiated spindle cell sarcoma - Tumour of intermediate malignancy - Atypical lipomatous tumour - Intermediate chondrogenic tumours - Atypical cartilaginous tumour - Cartilaginous tumour of uncertain prognosis - Chondromatosis NOS - Intermediate fibroblastic/myofibroblastic tumours - Dermatofibrosarcoma protuberans - Desmoid-type fibromatosis - Desmoplastic fibroma of bone - Fibro-osseous tumour of bone NOS - Fibrosarcomatous dermatofibrosarcoma protuberans - Giant cell fibroblastoma - Infantile fibrosarcoma - Inflammatory myofibroblastic tumour - Intermediate risk solitary fibrous tumour - Lipofibromatosis - Low grade myofibroblastic sarcoma - Low risk solitary fibrous tumour - Myxoinflammatory fibroblastic sarcoma - NTRK-rearranged spindle cell neoplasm - Palmar/plantar fibromatosis - Superficial CD34-positive fibroblastic tumour - Intermediate fibrohistiocytic tumours - Giant cell tumour of bone - Giant cell tumour of soft tissues - Metastatic giant cell tumour of bone - Osseous tumour rich in giant cell NOS - Plexiform fibrohistiocytic tumour - Suspicion of giant cell tumour of bone - Intermediate osteogenic tumours - Osteoblastoma NOS - Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma) - Intermediate peripheral nerve sheath tumour - Malignant melanotic neural tumour - Intermediate tumours of uncertain differentiation - Aneurysmal bone cyst - Angiomatoid fibrous histiocytoma - Atypical fibroxanthoma - Cutaneous pleomorphic sarcoma - Hemosiderotic fibrolipomatous tumour - Lymphangioleiomyoma/lymphangioleiomyomatosis - Malignant phosphaturic mesenchymal tumour - Melanotic neuroectodermal tumour of infancy - Mesenchymal tumor with GLI1 alteration - Mixed tumour - Myoepithelioma - Ossifying fibromyxoid tumour - PECOMA - NOS - Phosphaturic mesenchymal tumour NOS - Intermediate vascular tumours - Composite hemangioendothelioma - Epithelioid vascular tumour of bone NOS - Kaposi sarcoma - Kaposiform hemangioendothelioma - Papillary intralymphatic angioendothelioma - Pseudomyogenic hemangioendothelioma - Retiform hemangioendothelioma - Other tumours of intermediate malignancy - Atypical smooth muscle tumour - EBV-associated smooth muscle tumour (STUMP) - Endometrial stromal nodule - Endometrial stromal tumor low-grade - Inflammatory rhabdomyoblastic tumour - Metastatic leiomyoma - Smooth muscle tumour of undetermined malignant potential (STUMP) - Uterine tumour resembling ovarian sex cord tumours (UTROSCT) - Other intermediate mesenchymal tumour of bone - Mesenchymoma NOS - Osteofibrous dysplasia-like adamantinoma

TRIAL (5 items)

Clinical trial
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Essai Clinique dans lequel le patient est inclus
Possible values : RT-SU, Other, PAL ANGI 3, SYNFRIZZ, LMS-02, TRUST 62091 EORTC, PAZOGIST, T-DIS-1001, CASSANDRE-1108, APLIPO, ANGIONEXT 0710, LMS-03 (Sarcome 11), DESMOPAZ, ANGIOTAX-PLUS-0906, TOMOREP, FIBROMATOSE WS-RT, DFSP-PAZO, OS II TTP, AcSé Crizotinib, VIT 0910, REGOSARC-1214, CHONDROG, ESTIM LBH, RMS 2005, NRSTS 2005 EPSSG, OS 2006 (Sarcome 9), STRASS 62092 EORTC, Euro-Ewing 99 (Sarcome 1 - EORTC 62981), API-AI (Sarcome 3), 08 SARC 01 (RT-Sarc), SARC-GYN 1, PALSAR II 98 (Sarcome 2), TEPOSSE, ANGI-HE-1110, OUTC'S, GENEWING, SARI, ProActYon, RETROSPECTYON, ISKS , PROFILER, POLY NCR3-TNF GIST, SARCOLIGO, TKI-CPK-1003, IFOS-1, SAKK 56-07, Sarcome 07/0410 (Sarcome 7), Sarcome 04/0205 (Sarcome 4), Sarcome 08/0411 EORTC 62024 (Sarcome 8), EORTC 90061, EORTC 62061, BFR14, SURGIST Sarcome 10/0805 62063 (Sarcome 10), EORTC 62012, EUROSARC ISG-STS 10-01, CREATE EORTC 90101, GOG 0277 / EORTC 55116-62114, ImadGIST, CABONE, CHONRAD, ALDOXORUBICIN-P3-STS-01, EORTC 1202, REGOBONE, HGUS EORTC-62113-55115-STBSG-GCG, CYCLIGIST, EORTC 62005, EORTC 62011, EORTC 62991-22998, EORTC 62022, RAPIRI, BERNIE BO20924, TED12318, CSTI571X2103, NBTXR3, CSTI571X2101-BKM120, NP28021, PeComa, DOVIGIST, AB07001, VE-BASKET, AB11002, E7389-G000-309 ESAI, AB04030, Y-Image, PALETTE VEG110727 62072, VEG105430 GW786034, PO4720, E7389-E044-207 / EORTC 62052, A6181112, A6181004, A6181047, SUCCEED AP 23573-07-32, H3E-EW-S115, CAMN 107 A2103, CAMN 107 A2201, CAMN 107 G2301, CAMN 107 DDE06, CSTI571 JDE74, AMG162 20042006, EPIGIST, EFC 10145, SARC 011 N021157, ET-C-002-07, SABINE, AMG 655 20060324, ET-B-028-06, ET743-OVC-1001, CP13-0707, NP22890, OP690, PICASSO IPM 3001, BAY 73-4506/14874, IPI-926-04, NO21280, NGR-hTNF NGR 016, ET-B008-98 ET743, CSTI571 0203 EORTC 62001-16003 , CRAD001C 2206 , ET743-STS-201 , AB04016, ET743-SAR-1001 , 62043 EORTC, MORAb-004, TH-CR-406 / SARC 021, BP27772, A6181196, BRF 117019 , A4021020, ATRIGE, ZALYPSIS PM104-B-003-10, NBTXR3 301, LDE225, GENSARC, PVNS, VERSATIS faisabilité, NFITOR, NUTLIN 3 - MDM-2 - RO5503781, LEE011 phase I/II liposarcome, LEE011 phase I tumeurs solides, TSAR, CHDM201X2103C, Euro Ewing 2012, PEMBROSARC, SBRT Pédiatrie, ICGC LEIOMYOSARCOMES GSF, BP29428, MARGIC : Evaluation médico-économique, CCGM097X2101, GENMODIF, EQUIMETH2, HEPATOFLUO, MOST (My Own Specific Therapy), SHIVA - Phase II Preuve de concept, MOZOBIL15609 , SALTO-BIO , SALTO-2, SALTO, PACIFIK- GP28153, ABI-007-PST-001 - pédiatrie, KF5503-66, PROSPECTYON, AMG 232, rEECur EORTC 1403: sarcome d'Ewing, GC-BIO-IPC 2013-010, PERMED01-IPC 2014-003, ALTITUDES-1508 , RADIOSARP, PROPAN01, MorphinOgel, GEIS-32 , BLU-285-1101, EZH-202 , PLX108-10, OTMRG, GO28399, ALT GIST, MEME, CRYODESMO, MAPPYACTS, MO29518 BASKET, TRASTS, ET16-047 GIGIST-LB, I5B-MC-JGDJ : ANNOUNCE Ph III, I5B-MC-JGDM , MOTION - méta osseuses - Cryoablation, FIVE PRIME FPA008-002, AcSé-eSMART-CSET, LMS-04, HOPE 207, COMBINAIR3, IMODI, STARTRK-2 (RXDX-101-02), STOP MUCITES , MetZolimOS, ISI-JX, CLDK378A2407 ASCEND10, THEODORA, CABOGIST EORTC 1317 , RNASARC, CRAD001X2109, AVARTHEC, REVENRI, DCC-2618-03-001 INVICTUS, AcSé pembrolizumab, ANITA EORTC1506 , 20140114 DENO, XGEVA AMGEN 20150360, MICCHADO, TAPPAS 105SAR301 TRACON , PROFILER 02, EORTC-1506-STBSG-ANITA, KCP-330-020 SEAL :Selinexor vs Placebo liposarcome, TRAMUNE : ph IB_trabectidine Durvalumab , IsèreADOM, PHRC ETOILE, Sarcome 13 / OS2016, I6F-MC-JJCD, ALCINA, CA209-848, BLU-285-1303 VOYAGER, EORTC 1447-STBSG, EZH-501, NEOSARCOMICS, METRO PD1, RT-Immune, REGOMUNE, ARO-012 CRENOGIST, ETIOSARC, 1443.0001 : phI_BI765063 , DCC-2618-03-002 INTRIGUE, EREMISS: Ph II_regorafenif en maintenance_sarcome, 2102-ONC-102: Ph Ib/II_FT-2102t , COTESARC ML41313, BFR ESS 01: sarcome stromal de l'endomètre, REGISTRI, cirsarc, CONGRATS, E7389-G000-213, 1200.120 : afatinib, PAIRS AJA, CHANCE, ONCOVID-19: SRAS-COV2 , MULTISARC C16-40, REGOSTAT, MEDIPA, SPECTA EORTC 1553, MEGAMOST, 42756493CAN2002 RAGNAR, ONCOVID-21, ADP-0044-002 SPEARHEAD 1, PROTONBIOMARKS: biomarqueurs_ péd et adultes, PASCA: PArcours de Santé au cours du CAncer, LENVAGIST: ph II_lenvatinib + MSS vs MSS_GIST, RAR-IMMUNE, KETACANCER , 208467 IGNYTE ESO, CHIC STS 01, Ce NGEPS-GMFMel ("RIC MEL") , ANRS0001S CoV-POPART , RTSG 2016 UMBRELLA , SUDOPED, PRESOV, REGOMAIN, EORTC 1809STRASS 2, PLANET, AMPHISARC: Ph I/II, OP2C - Observatoire, SACHA: Etude prospective obs_péd, MIRAS, EORTC QLG: sarcome _ QDV, GERICO 14 , ATEZOGIST, GSK 213406, DUNE, AVIATOR2020, FHD-609-C-001, ZN-c3-003, RADIOSARC: MR004 RT _sarcome tissus mous , INBRX109: ph II_ INBRX-109 chondrosarcome, BI 1403-0008, OSII-TTP, MK7902-013, THERAC, PTC596-ONC-008, FaR-RMS, TARSARC : Ph II_ sarcome tissus mous ATR, STEREOSARC, FORTEe : Fort contre le cancer, RAIN-3201 MANTRA, TPN-RAD, IMPRESARC, OSE-279 - C101, ADCT-601-102, TRacKING, PICCandGLUE, GO42286, PH-L19TNFDOX2-03/16 FIBROSARC, TORNADO, NB003-01, BEVANEC, PM1183-C-010-22, DEBOUT-HOSPIT, PH-L19TNFSARC-03/18 FLASH: sarcome tissus mous, IDRX-42-001, PROPHYLOXITIN, SarQuantIRM, CGT9486-21-301(PEAK), AcSé – Vemurafenib , PEMBROCABOSARC, HYPOSARC, PM1183-C-010-22 SALUDO, REGO INTER EWING-1, MAPPYACTS 2, DCC-2618-03-003 (INSIGHT), LPSM, COHEC: PhIII_RIPH2, INBRX-109 EWING , OnKOT&T 2.0, Pelvtilt-RT, Sleep-4-all-2.0, DS2243-054 , CANUT Junior, L-UteCIN , ePPS-2202, HOPAYA, CRYODESMO-2, IMC-P115C-1005, OMX-0407-101: PhIb_ OMX-0407 , CHONQUER, PREDOSTAR: Ph II_Dostarlimab, QF-EXPERT: RIPH3, GIST-Ten , ADCE-D01-001 Adcendo , LIGHT-CTC, TANGENT SNX-301-020, StrateGIST 3, AFTERGYN, EZHiSWITCH CSET 2024, StrateGIST 3 IDRX-42-301, ESPACE, PREDCAP

Clinical trial other
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

Inclusion date
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date de l'inclusion dans l'essai clinique (signature du consentement)

Centre of treatment
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Établissement dans lequel le patient est inclus dans l'essai clinique
Possible values : CC Bordeaux CLCC/CHU, CC Lyon CLCC/CHU, CC IGR, CE Angers CLCC/CHU, CE Besançon CLCC/CHU, CE Caen CLCC/CHU, CE Clermond-Ferrand CLCC/CHU, CE Dijon CLCC/CHU, CE La Réunion, CE Lille CLCC/CHU, CE Limoges CHU, CE Marseille CHU Timone, CE Marseille CLCC, CE Montpellier CLCC/CHU, CE Nancy CLCC/CHU, CE Nantes CLCC, CE Nantes CHU, CE Nice CLCC/CHU, CE Paris Pitié Salpétrière, CE Paris Tenon , CE Paris Cochin, CE Paris Curie , CE Paris Saint Louis, CE Reims CLCC/CHU, CE Rennes/Brest CLCC/CHU, CE Rouen CLCC/CHU, CE Strasbourg CLCC/CHU, CE Toulouse CLCC/CHU, CE Tours CHU, Autre

File number
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Numéro de dossier du patient dans votre établissement

SarcomaBCB

Backoffice